<SEC-DOCUMENT>0000070858-25-000195.txt : 20250424
<SEC-HEADER>0000070858-25-000195.hdr.sgml : 20250424
<ACCEPTANCE-DATETIME>20250424171028
ACCESSION NUMBER:		0000070858-25-000195
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20250422
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Submission of Matters to a Vote of Security Holders
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250424
DATE AS OF CHANGE:		20250424

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BANK OF AMERICA CORP /DE/
		CENTRAL INDEX KEY:			0000070858
		STANDARD INDUSTRIAL CLASSIFICATION:	NATIONAL COMMERCIAL BANKS [6021]
		ORGANIZATION NAME:           	02 Finance
		EIN:				560906609
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-06523
		FILM NUMBER:		25868856

	BUSINESS ADDRESS:	
		STREET 1:		BANK OF AMERICA CORPORATE CENTER
		STREET 2:		100 N TRYON ST
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28255
		BUSINESS PHONE:		7043868486

	MAIL ADDRESS:	
		STREET 1:		BANK OF AMERICA CORPORATE CENTER
		STREET 2:		100 N TRYON ST
		CITY:			CHARLOTTE
		STATE:			NC
		ZIP:			28255

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	BANKAMERICA CORP/DE/
		DATE OF NAME CHANGE:	19981022

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NATIONSBANK CORP
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NCNB CORP
		DATE OF NAME CHANGE:	19920107
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>bac-20250422.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2cc093cd-33e9-4e28-9f1d-e9dcb35803c7,g:07d1049a-4b93-4e26-bdd7-e13d1ffcf13e,d:c0d2fe22297b495ab6f560c30ae03d60-->
<html xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:bac="http://www.bankofamerica.com/20250422" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>bac-20250422</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-77">0000070858</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-78">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="bac-20250422.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesGGPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesHHPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesLPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series1PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series2PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series4PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series5PreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:FloatingRatePreferredHybridIncomeTermSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:IncomeCapitalObligationNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeniorMediumTermNotesSeriesAStepUpCallableNotesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesKKPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesLLPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesNNPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesPPPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesQQPreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000070858</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2025-04-22</xbrli:startDate><xbrli:endDate>2025-04-22</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ic0d2fe22297b495ab6f560c30ae03d60_1"></div><div style="min-height:42.75pt;width:100%"><div style="padding-left:180pt;text-indent:36pt"><span><br/></span></div></div><div style="-sec-extract:summary;margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> As filed with the Securities and Exchange Commission on April 24, 2025 </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1"><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-2"><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-3">8-K</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PURSUANT TO SECTION 13 OR 15(d) OF THE</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-4">April 22, 2025</ix:nonNumeric> </span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-5">BANK OF AMERICA CORPORATION</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.830%"><tr><td style="width:1.0%"/><td style="width:30.852%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.077%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.758%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:30.855%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-6">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-7">1-6523</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-8">56-0906609</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or Other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="margin-top:4pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-9">100 North Tryon Street</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-10">Charlotte</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-11">North Carolina</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-12">28255</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-13">704</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-14">386-5681</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Registrant&#8217;s telephone number, including area code)</span></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Not Applicable </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:4.756%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:93.044%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-18">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="padding-left:180pt;text-indent:36pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:46.400%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.105%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.195%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-2" name="dei:Security12bTitle" id="f-19">Common Stock, par value $0.01 per share</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:TradingSymbol" id="f-20">BAC</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-2" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-21">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-3" name="dei:Security12bTitle" id="f-22">Depositary Shares, each representing a 1/1,000th interest in a share  of Floating Rate Non-Cumulative Preferred Stock, Series E</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:TradingSymbol" id="f-23">BAC PrE</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-3" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-24">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-4" name="dei:Security12bTitle" id="f-25">Depositary Shares, each representing a 1/1,000th interest in a share of 6.000% Non-Cumulative Preferred Stock, Series GG</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:TradingSymbol" id="f-26">BAC PrB</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-4" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-27">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-5" name="dei:Security12bTitle" id="f-28">Depositary Shares, each representing a 1/1,000th interest in a share of 5.875% Non-Cumulative Preferred Stock, Series HH</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:TradingSymbol" id="f-29">BAC PrK</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-5" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-30">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-6" name="dei:Security12bTitle" id="f-31">7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:TradingSymbol" id="f-32">BAC PrL</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-6" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-33">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-7" name="dei:Security12bTitle" id="f-34">Depositary Shares, each representing a 1/1,200th interest in a share of</ix:nonNumeric> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:TradingSymbol" id="f-35">BML PrG</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-7" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-36">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bank of America Corporation Floating Rate Non-Cumulative </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred Stock, Series 1</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-8" name="dei:Security12bTitle" id="f-37">Depositary Shares, each representing a 1/1,200th interest in a share of</ix:nonNumeric> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-8" name="dei:TradingSymbol" id="f-38">BML PrH</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-8" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-39">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bank of America Corporation Floating Rate Non-Cumulative</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred Stock, Series 2</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-9" name="dei:Security12bTitle" id="f-40">Depositary Shares, each representing a 1/1,200th interest in a share of</ix:nonNumeric> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-9" name="dei:TradingSymbol" id="f-41">BML PrJ</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-9" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-42">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bank of America Corporation Floating Rate Non-Cumulative</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred Stock, Series 4</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-10" name="dei:Security12bTitle" id="f-43">Depositary Shares, each representing a 1/1,200th interest in a share of</ix:nonNumeric> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-10" name="dei:TradingSymbol" id="f-44">BML PrL</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-10" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-45">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Bank of America Corporation Floating Rate Non-Cumulative <br/></span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Preferred Stock, Series 5</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-11" name="dei:Security12bTitle" id="f-46">Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIII (and the guarantee related thereto)</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-11" name="dei:TradingSymbol" id="f-47">BAC/PF</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-11" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-48">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-12" name="dei:Security12bTitle" id="f-49">5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIV (and the guarantee related thereto)</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-12" name="dei:TradingSymbol" id="f-50">BAC/PG</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-12" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-51">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-13" name="dei:Security12bTitle" id="f-52">Income Capital Obligation Notes initially due December 15, 2066 of Bank of America Corporation</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-13" name="dei:TradingSymbol" id="f-53">MER PrK</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-13" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-54">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-14" name="dei:Security12bTitle" id="f-55">Senior Medium-Term Notes, Series A, Step Up Callable Notes, due</ix:nonNumeric> </span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-14" name="dei:TradingSymbol" id="f-56">BAC/31B</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-14" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-57">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">November 28, 2031 of BofA Finance LLC (and the guarantee of the </span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Registrant with respect thereto)</span></td><td colspan="3" style="border-left:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-15" name="dei:Security12bTitle" id="f-58">Depositary Shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series KK</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-15" name="dei:TradingSymbol" id="f-59">BAC PrM</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-15" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-60">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-16" name="dei:Security12bTitle" id="f-61">Depositary Shares, each representing a 1/1,000th interest in a share of 5.000% Non-Cumulative Preferred Stock, Series LL</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-16" name="dei:TradingSymbol" id="f-62">BAC PrN</ix:nonNumeric><br/></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-16" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-63">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-17" name="dei:Security12bTitle" id="f-64">Depositary Shares, each representing a 1/1,000th interest in a share of 4.375% Non-Cumulative Preferred Stock, Series NN</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-17" name="dei:TradingSymbol" id="f-65">BAC PrO</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-17" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-66">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-18" name="dei:Security12bTitle" id="f-67">Depositary Shares, each representing a 1/1,000th interest in a share of 4.125% Non-Cumulative Preferred Stock, Series PP</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-18" name="dei:TradingSymbol" id="f-68">BAC PrP</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-18" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-69">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-19" name="dei:Security12bTitle" id="f-70">Depositary Shares, each representing a 1/1,000th interest in a share of 4.250% Non-Cumulative Preferred Stock, Series QQ</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-19" name="dei:TradingSymbol" id="f-71">BAC PrQ</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-19" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-72">New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-20" name="dei:Security12bTitle" id="f-73">Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-20" name="dei:TradingSymbol" id="f-74">BAC PrS</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-20" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-75">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:95.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company     </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-76">&#9744;</ix:nonNumeric></span></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:95.811%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:1.989%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.     </span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="padding-left:180pt;text-indent:36pt"><span><br/></span></div></div><div style="padding-left:94.5pt;text-indent:-94.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:103%">Item&#160;5.02.  Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e) On April 22, 2025, Bank of America Corporation (the &#8220;Corporation&#8221;) held its 2025 Annual Meeting of Shareholders (the &#8220;Annual Meeting&#8221;). At the Annual Meeting, the Corporation&#8217;s shareholders approved the amendment and restatement of the Bank of America Corporation Equity Plan (&#8220;Plan&#8221;) to (i) increase the number of shares available for grant by 100 million; (ii) limit the value of shares granted to a non-employee director in a calendar year, together with any cash fees paid during the calendar year, to $1 million in total value, with certain donation and special service exceptions; and (iii) extend the expiration date of the Plan from April 24, 2033 to April 21, 2035. The Plan&#8217;s terms are otherwise substantially unchanged.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A description of the material terms and conditions of the Plan, as amended and restated, appears on pages 82-88 of the Corporation&#8217;s definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on March 10, 2025. That description, a copy of which is filed as Exhibit 99.1 hereto and is incorporated into this Item 5.02(e) by reference, does not purport to be complete, and is qualified in its entirety by reference to the full text of the amended and restated Plan attached as Exhibit 10.1 to this report and incorporated into this Item 5.02(e) by reference.</span></div><div style="margin-top:6pt;padding-left:72pt;text-indent:-72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item&#160;5.07.  Submission of Matters to a Vote of Security Holders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:174%">(a)&#160;On April&#160;22, 2025, the Corporation held its Annual Meeting.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;The Corporation&#8217;s shareholders: elected all of the nominees for director; approved the advisory vote on executive compensation; ratified the appointment of PricewaterhouseCoopers LLP as the Corporation&#8217;s independent registered public accounting firm for 2025; and approved the amendment and restatement of the Plan. The Corporation&#8217;s shareholders did not approve the shareholder proposals listed below. With respect to all matters subject to a vote, holders of the Corporation&#8217;s common stock, Series B Preferred Stock, and Series 1, 2, 4, and 5 Preferred Stock voted together as a class.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:25.800%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.601%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.332%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.034%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.408%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.043%"/><td style="width:0.1%"/></tr><tr><td colspan="39" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">1.  Electing directors:</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">For</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Against</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Abstain</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="6" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Broker <br/>Non-Votes</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sharon L. Allen</span></td><td colspan="9" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,366,712,605</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">260,206,920</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,364,916</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jos&#233; E. Almeida</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,539,160,076</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">86,353,341</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,771,024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pierre J.P. de Weck</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,416,131,342</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">208,402,421</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,750,678</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Arnold W. Donald</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,318,394,562</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">308,309,111</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,580,768</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Linda P. Hudson</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,464,540,490</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">162,094,318</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,649,633</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Monica C. Lozano</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,287,843,089</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">338,067,547</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,373,805</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maria N. Martinez</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,590,130,879</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,935,265</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,218,297</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Brian T. Moynihan</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,176,804,387</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">451,446,518</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,033,536</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lionel L. Nowell III</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,416,464,282</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209,682,980</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,137,179</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denise L. Ramos</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,538,620,834</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">87,690,413</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,973,194</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Clayton S. Rose</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,531,726,689</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,744,955</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,812,797</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael D. White</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,453,066,173</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">173,070,305</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,147,963</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thomas D. Woods</span></td><td colspan="9" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,555,880,107</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,380,092</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,024,242</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maria T. Zuber</span></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,249,297,024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">376,967,680</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,019,737</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:84.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.542%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2.  Approving the Corporation&#8217;s executive compensation (an advisory, non-binding &#8220;Say on Pay&#8221; resolution):</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,134,323,650&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,483,801,400&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,159,391&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">3. Ratifying the appointment of the Corporation&#8217;s independent registered public accounting firm for 2025:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,049,792,292&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">382,069,179&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">21,100,404&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="padding-left:180pt;text-indent:36pt"><span><br/></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4. Amending and restating the Bank of America Corporation Equity Plan:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,255,035,970&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,364,368,577&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,879,894&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">5. Shareholder proposal - requesting the nomination of more director candidates than board seats:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">93,403,817&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,521,489,525&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,391,099&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6. Shareholder proposal - requesting report on board oversight of risks related to animal welfare:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">357,167,054&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,229,397,462&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56,719,925&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">7. Shareholder proposal - requesting report on lobbying alignment with Bank of America&#8217;s climate goals:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">907,063,904&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,690,427,599&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">45,792,938&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.415%"><tr><td style="width:1.0%"/><td style="width:84.194%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.606%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">8. Shareholder proposal - requesting disclosure of energy financing ratio:</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">For</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">916,014,683&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Against</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,684,750,242&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Abstain</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,519,516&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Broker Non-Votes</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">809,677,434&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="padding-left:180pt;text-indent:36pt"><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Item 9.01. Financial Statements and Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(d) Exhibits.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exhibits 10.1 and 99.1 are filed herewith.</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.245%"><tr><td style="width:1.0%"/><td style="width:14.971%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:82.829%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">EXHIBIT NO.</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">DESCRIPTION OF EXHIBIT</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex101-4x22x25.htm">10.1</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex101-4x22x25.htm">Bank of America Corporation Equity Plan</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex101-4x22x25.htm">, as amended and restated effective April 2</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex101-4x22x25.htm">2</a><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex101-4x22x25.htm">, 202</a>5</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex991.htm">99.1</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0e32e1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;text-decoration:underline" href="ex991.htm">Description of Bank of America Corporation Equity Plan</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">104</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded in the cover page formatted in Inline XBRL)</span></div></td></tr></table></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="padding-left:180pt;text-indent:36pt"><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span><br/></span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-top:9pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.198%"><tr><td style="width:1.0%"/><td style="width:44.340%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.586%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:46.774%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BANK OF AMERICA CORPORATION</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Ross E. Jeffries, Jr.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ross E. Jeffries, Jr.</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deputy General Counsel and Corporate Secretary</span></td></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: April 24, 2025 </span></div><div><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101-4x22x25.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i8f788f7cdf184df393539ad4c9763813_1"></div><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Exhibit 10.1</font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.2pt"><font><br></font></div><div style="margin-top:4.5pt;padding-left:204.15pt;padding-right:204.15pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bank of America Corporation Equity Plan</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="margin-top:0.45pt"><font><br></font></div><div style="padding-left:145.2pt;padding-right:145.2pt;text-align:center;text-indent:32.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Original Effective Date&#58; January 1, 2003 Amended and Restated Effective Date&#58; April 22, 2025</font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="padding-right:144.7pt"><font><br></font></div><div style="margin-top:3.75pt;padding-left:6pt"><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-indent:5.04pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Contents</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.714%"><tr><td style="width:1.0%"></td><td style="width:94.436%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:3.364%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 1. Establishment, Duration and Purpose</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 2. Definitions</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 3. Administration</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 4. Shares Subject to the Plan</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 5. Eligibility and Participation</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 6. Stock Options</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 7. Stock Appreciation Rights</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 8. Restricted Stock and Restricted Stock Units</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 9. Performance Measures</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">14</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 10. Beneficiary Designation</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 11. Deferrals</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 12. Rights of Employees</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 13. Change in Control</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">15</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 14. Amendment, Modification, and Termination</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">17</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 15. Withholding</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 16. Indemnification</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 17. Successors</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 18. Legal Construction</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">18</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Article 19. Non-Employee Directors</font></div></td><td colspan="3" style="padding:2px 3.77pt 2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">19</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div id="i8f788f7cdf184df393539ad4c9763813_88"></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.411%"><tr><td style="width:1.0%"></td><td style="width:31.328%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.956%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.416%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="padding-left:72pt;padding-right:72pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Bank of America Corporation</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Equity Plan</font></div><div style="margin-top:0.15pt"><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 1. Establishment, Duration and Purpose</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.1 Establishment and Duration of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company established this Plan, originally known as the &#8220;Bank of America Corporation Key Associate Stock Plan,&#8221; effective as of January 1, 2003, and the Plan as originally established was approved by the Company&#8217;s stockholders. The Plan, subsequently known as the &#8220;Bank of America Key Employee Equity Plan&#8221; and now known as the &#8220;Bank of America Corporation Equity Plan&#8221; was subsequently amended or amended and restated on several occasions, most recently with an amendment and restatement approved by the Company&#8217;s stockholders at the annual meeting of stockholders on April 24, 2024. The Plan is hereby being further amended and restated, subject to and effective upon the approval of the Company&#8217;s stockholders at the annual meeting of stockholders on April 22, 2025. The purposes of amending and restating the Plan are to (a) authorize additional Shares for Awards under the Plan, (b) extend the Plan&#8217;s term, and (c) add a limit on awards to Non-Employee Directors. The Plan shall remain in effect until the earliest of (i) the date that no additional Shares are available for issuance under the Plan, (ii) the date that the Plan has been terminated in accordance with Article 14 or (iii) the close of business on April 21, 2035.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">1.2 Purpose of the Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company believes that the compensation of its Employees should be linked to the Company&#8217;s business performance in order to enhance the long-term success and value of the Company. The Plan serves this compensation philosophy by providing a source of equity-based Awards for Employees that are intended to further motivate Employees to increase the value of the Company&#8217;s common stock, thereby aligning the interests of the Employees with those of the Company&#8217;s stockholders while maintaining an appropriate balance between risk and reward. The Plan also provides the Company with a means to attract, recruit and retain Employees who will create sustainable results consistent with the Company&#8217;s risk management policies and strategic plan for the long-term benefit of the Company&#8217;s stockholders. The Plan also enables the Company to attract and retain persons of exceptional ability to serve as Non-Employee Directors and to further align the interests of Non-Employee Directors and stockholders in enhancing the value of the Company&#8217;s Shares.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 2. Definition</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">s</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Whenever used in the Plan, the following terms shall have the meanings set forth below and, when the meaning is intended, the initial letter of the word is capitalized&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means, individually or collectively, a grant under this Plan of Nonqualified Stock Options, Incentive Stock Options, Stock Appreciation Rights, Restricted Stock or Restricted Stock Units.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Award Agreement&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an agreement between the Company and each Participant setting forth the terms and provisions applicable to Awards granted under this Plan.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Beneficial Owner&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Beneficial Ownership&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning ascribed to such term in Rule 13d-3 of the General Rules and Regulations under the Exchange Act.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Board&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Board of Directors&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Board of Directors of the Company.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">&#8220;Change in Control&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">of the Company means, and shall be deemed to have occurred upon, any of the following events&#58;</font></div><div style="text-indent:30.41pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) The acquisition by any Person of Beneficial Ownership of twenty-five percent (25%) or more of either&#58;</font></div><div style="text-indent:54.9pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-indent:54.9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) The then-outstanding Shares (the &#8220;Outstanding Shares&#8221;)&#59; or</font></div><div style="margin-bottom:5pt;padding-left:54.95pt;padding-right:15.8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)  The combined voting power of the then-outstanding voting securities of the Company entitled to                 &#160;&#160;&#160;&#160;                                                                                     vote generally in the election of Directors (the &#8220;Outstanding Voting Securities&#8221;)&#59;</font></div><div style="margin-bottom:5pt;padding-left:30.45pt;padding-right:6.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">provided, however, that the following acquisitions shall not constitute a Change in Control for purposes of this subparagraph (a)&#58; (A) any acquisition directly from the Company, (B) any acquisition by the Company or any of its Subsidiaries, (C) any acquisition by any employee benefit plan (or related trust) sponsored or maintained by the Company or any of its Subsidiaries, or (D) any acquisition by any corporation pursuant to a transaction which complies with clauses (i), (ii) and (iii) of subparagraph (c) below&#59; or</font></div><div style="margin-bottom:5pt;padding-left:30.45pt;padding-right:6.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b) Individuals who, as of the Effective Date, constitute the Board of Directors (the &#8220;Incumbent Board&#8221;) cease for any reason to constitute at least a majority of the Board of Directors&#59; provided, however, that any individual who becomes a Director subsequent to the Effective Date and whose election, or whose nomination for election by the Company&#8217;s stockholders, to the Board of Directors was either (i) approved by a vote of at least a majority of the Directors then comprising the Incumbent Board or (ii) recommended by a corporate governance committee comprised entirely of Directors who are then Incumbent Board members shall be considered as though such individual were a member of the Incumbent Board, but excluding, for this purpose, any such individual whose initial assumption of office occurs as a result of either an actual or threatened election contest, other actual or threatened solicitation of proxies or consents or an actual or threatened tender offer&#59; or</font></div><div style="padding-left:30.45pt;padding-right:6.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c) Consummation of a reorganization, merger, or consolidation or sale or other disposition of all or substantially all of the assets of the Company (a &#8220;Business Combination&#8221;), in each case, unless following such Business Combination, (i) all or substantially all of the Persons who were the Beneficial Owners, respectively, of the Outstanding Shares and Outstanding Voting Securities immediately prior to such Business Combination own, directly or indirectly, more than fifty percent (50%) of, respectively, the then outstanding shares of common stock and the combined voting power of the then outstanding voting securities entitled to vote generally in the election of directors, as the case may be, of the corporation resulting from the Business Combination (including, without limitation, a corporation which as a result of such transaction owns the Company or all or substantially all of the Company&#8217;s assets either directly or through one or more subsidiaries) in substantially the same proportions as their ownership, immediately prior to such Business Combination, of the Outstanding Shares and Outstanding Voting Securities, as the case may be (provided, however, that for purposes of this clause (i), any shares of common stock or voting securities of such resulting corporation received by such Beneficial Owners in such Business Combination other than as the result of such Beneficial Owners&#8217; ownership of Outstanding Shares or Outstanding Voting Securities immediately prior to such Business Combination shall not be considered to be owned by such Beneficial Owners for the purposes of calculating their percentage of ownership of the outstanding common stock and voting power of the resulting corporation), (ii) no Person (excluding any corporation resulting from such Business Combination or any employee benefit plan (or related trust) of the Company or such corporation resulting from the Business Combination) beneficially owns, directly or indirectly, twenty-five percent (25%) or more of, respectively, the then outstanding shares of common stock of the corporation resulting from the Business Combination or the combined voting power of the then outstanding voting securities of such corporation unless such Person owned twenty-five percent (25%) or more of the Outstanding Shares or Outstanding Voting Securities immediately prior to the Business Combination and (iii) at least a majority of the members of the board of directors of the corporation</font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:30.45pt;padding-right:6.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">resulting from such Business Combination were members of the Incumbent Board at the time of the</font></div><div style="margin-bottom:5pt;padding-left:30.45pt;padding-right:6.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">execution of the initial agreement, or the action of the Board, providing for such Business Combination&#59; or</font></div><div style="margin-bottom:5pt;padding-left:30.24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d) Approval by the Company&#8217;s stockholders of a complete liquidation or dissolution of the Company.</font></div><div style="padding-left:30.24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, if it is determined that an Award hereunder is subject to the requirements of Section 409A of the Code and the Change in Control is a &#8220;payment event&#8221; under Section 409A of the Code for such Award, then for such purpose the Company will not be deemed to have undergone a Change in Control unless the Company is deemed to have undergone a &#8220;change in control event&#8221; pursuant to the definition of such term in Section 409A of the Code.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Code&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Internal Revenue Code of 1986, as amended from time to time. References to the Code shall include the valid and binding governmental regulations, court decisions and other regulatory and judicial authority issued or rendered thereunder.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Committee&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Compensation and Human Capital Committee of the Board of Directors&#59; provided, however, that with respect to Awards to any Employees who are Insiders, Committee means all of the members of the Compensation and Human Capital Committee who are &#8220;non-employee directors&#8221; within the meaning of Rule 16b-3 adopted under the Exchange Act. Committee may also mean any individual or committee of individuals (who need not be Directors) that the Compensation and Human Capital Committee may appoint from time to time to administer the Plan with respect to Awards to Employees who are not Insiders, in accordance with and subject to the requirements of Section 3.2.</font></div><div><font><br></font></div><div style="text-indent:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Company&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means Bank of America Corporation, a Delaware corporation, and any successor as provided in Article 17 herein.</font></div><div><font><br></font></div><div style="text-indent:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Director&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means any individual who is a member of the Board of Directors of the Company.</font></div><div><font><br></font></div><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Disability&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with respect to a Participant, means &#8220;disability&#8221; as defined from time to time under any long-term disability plan of the Company or Subsidiary with which the Participant is employed. Notwithstanding the foregoing, for any Awards that constitute nonqualified deferred compensation within the meaning of</font></div><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 409A(d) of the Code and provide for an accelerated payment in connection with any Disability, Disability shall have the same meaning as set forth in any regulations, revenue procedure, revenue rulings or other pronouncements issued by the Secretary of the United States Treasury pursuant to Section 409A of the Code, applicable to such arrangements.</font></div><div><font><br></font></div><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Effective Date&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means April 22, 2025.</font></div><div><font><br></font></div><div style="text-indent:5.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Employee&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an employee of the Company or any Subsidiary, including an officer of the Company or a Subsidiary, who, by virtue of such employee&#8217;s position, ability, qualifications and performance, has made, or is expected to make, important contributions to the Company or its Subsidiaries, all as determined by the Committee in its discretion.</font></div><div><font><br></font></div><div style="text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Exchange Act&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the Securities Exchange Act of 1934, as amended from time to time, or any successor act thereto.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Fair Market Value&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">of a Share on any date means the closing price of a Share as reflected in the report of composite trading of New York Stock Exchange listed securities for that day (or, if no Shares were publicly traded on that day, the immediately preceding trading day that Shares were so traded) as published in The Wall</font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Street Journal Eastern Edition or in any other publication selected by the Committee&#59; provided, however, that</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">if the Shares are misquoted or omitted by the selected publication(s), the Committee shall directly solicit the</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">information from officials of the stock exchanges or from other informed independent market sources.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Incentive Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;ISO&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an option to purchase Shares granted to an Employee under Article 6 herein, and designated as an Incentive Stock Option which is intended to meet the requirements of</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 422 of the Code.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Insider&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall mean an individual who is, on the relevant date, an officer, director or ten percent (10%) beneficial owner of any class of the Company&#8217;s equity securities that is registered pursuant to Section 12 of the Exchange Act, all as defined under Section 16 of the Exchange Act and the rules thereunder.</font></div><div><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Non-Employee Director&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an individual who is a member of the Board, but who is not an employee of the Company or any of its Subsidiaries.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Nonqualified Stock Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;NQSO&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an option to purchase Shares granted to an Employee under Article 6 herein, and which is not intended to meet the requirements of Code Section 422.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Option&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an Incentive Stock Option or a Nonqualified Stock Option.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Option Price&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the price at which a Share may be purchased by a Participant pursuant to an Option.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Participant&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an Employee, a former Employee or any permitted transferee under the Plan of an Employee or former Employee who has outstanding an Award granted under the Plan.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Performance Award&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an Award of Shares of Restricted Stock or Restricted Stock Units made subject to the attainment of performance goals over a performance period established by the Committee as described in Article 9.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Period of Restriction&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the period during which the transfer of Shares of Restricted Stock or an Award of Restricted Stock Units is limited in some way or during which such Award is subject to a risk of forfeiture (based on the passage of time, the achievement of performance goals, or upon the occurrence of other events as determined by the Committee, at its discretion), as provided in Article 8 herein and subject to Section 3.4.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Person&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">shall have the meaning ascribed to such term in Section 3(a)(9) of the Exchange Act and used in Sections 13(d) and 14(d) thereof, including a &#8220;group&#8221; within the meaning of Section 13(d).</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Plan&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the incentive compensation plan set forth herein known as the &#8220;Bank of America Corporation Equity Plan,&#8221; as the same may be amended from time to time. Previously, the Plan was known as the &#8220;Bank of America Corporation Key Associate Stock Plan.&#8221;</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Restricted Stock&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an Award of Shares, subject to a Period of Restriction (except as set forth in Section 3.4), that is granted to an Employee under Article 8 herein or a Non-Employee Director under Article 19 herein.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Restricted Stock Unit&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an Award, subject to a Period of Restriction (except as set forth in Section 3.4), that is granted to an Employee under Article 8 herein and is settled either (a) by the delivery of one (1) Share for each Restricted Stock Unit or (b) in cash in an amount equal to the Fair Market Value of one (1) Share for each Restricted Stock Unit, all as specified in the applicable Award Agreement. The Award of a Restricted Stock Unit represents the mere promise of the Company to deliver a Share or the appropriate amount of cash, as applicable, at the end of the Period of Restriction (or such later date as provided by the Award Agreement) in</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">accordance with and subject to the terms and conditions of the applicable Award Agreement, and is not intended to constitute a transfer of &#8220;property&#8221; within the meaning of Section 83 of the Code.</font></div><div><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Shares&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means the shares of common stock of the Company.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Stock Appreciation Right&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SAR&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means an Award designated as an SAR that is granted to an Employee under Article 7 herein.</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#8220;Subsidiary&#8221; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">means any corporation, partnership, joint venture, affiliate, or other entity in which the Company owns more than fifty percent (50%) of the voting stock or voting ownership interest, as applicable, or any other business entity designated by the Committee as a Subsidiary for purposes of the Plan.</font></div><div><font><br></font></div><div style="margin-bottom:8pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 3. Administration</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.1 Authority of the Committee</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan shall be administered by the Committee. Except as limited by law, or by the Certificate of Incorporation or Bylaws of the Company, and subject to the provisions herein, the Committee shall have full power to select Employees who may receive an Award under the Plan&#59; determine the sizes and types of Awards&#59; determine the terms and conditions of Awards in a manner consistent with the Plan&#59; construe and interpret the Plan and any agreement or instrument entered into under the Plan&#59; establish, amend, or waive rules and regulations for the Plan&#8217;s administration&#59; and (subject to the provisions of Article 14 herein), amend the terms and conditions of any outstanding Award to the extent such terms and conditions are within the discretion of the Committee as provided in the Plan. Further, the Committee shall make all other determinations which may be necessary or advisable for the administration of the Plan.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.2 Delegation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the extent permitted by applicable law, the Committee may delegate its authority as identified herein to any individual or committee of individuals (who need not be Directors), including without limitation the authority to make Awards to Employees who are not Insiders. To the extent that the Committee delegates its authority to make Awards as provided by this Section 3.2, all references in the Plan to the Committee&#8217;s authority to make Awards and determinations with respect thereto shall be deemed to include the Committee&#8217;s delegate. Any such delegate shall serve at the pleasure of, and may be removed at any time by, the Committee.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.3 Decisions Binding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. All determinations and decisions made by the Committee pursuant to the provisions of the Plan and all related orders and resolutions of the Board shall be final, conclusive and binding on all persons, including the Company, its stockholders, employees, Participants, and their estates and beneficiaries.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">3.4 Limitation on Vesting for Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan to the contrary including but not limited to this Section 3.4, stock-settled Awards granted under the Plan shall not vest more quickly than ratably annually as of each anniversary over the three (3) year period beginning on the Award grant date, excluding, for this purpose, any (i) Awards granted through the assumption of, or in substitution for, outstanding awards previously granted to individuals who become Employees as a result of a merger, consolidation, acquisition or other corporate transaction involving the Company or any Subsidiary, (ii) Shares delivered in lieu of fully vested cash incentive compensation under any applicable plan or program of the Company, (iii) Awards to Non-Employee Directors that vest on the earlier of the one year anniversary of the date of grant or the next annual meeting of stockholders (provided that such vesting period under this clause (iii) may not be less than 50 weeks after grant), and (iv) Awards that become vested based on the achievement of performance goals over a period of at least one year&#59; provided, that, the Board may grant stock-settled Awards without regard to the foregoing minimum vesting requirement with respect to a maximum of five percent (5%) of the available share reserve authorized for issuance under the Plan pursuant to Section 4.1 (subject to adjustment under Section 4.6)&#59; and, provided further, for the avoidance of doubt, that the foregoing</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> restriction does not apply to the Committee&#8217;s discretion to provide for accelerated exercisability or vesting of any Award, including in cases of retirement, workforce reduction, death, disability or a Change in Control, in the terms of the Award or otherwise.</font></div><div><font><br></font></div><div style="margin-bottom:15pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 4. Shares Subject to the Plan</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.1 Number of Shares Available for Grants</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the provisions of this Article 4, the aggregate number of Shares available for grants of Awards under the Plan from and after January 1, 2015 shall not exceed the sum of (A) four hundred fifty million (450,000,000) Shares plus (B) any Shares that were subject to an award as of December 31, 2014 under this Plan, if such award is canceled, terminates, expires, lapses or is settled in cash for any reason from and after January 1, 2015 plus (C) effective upon April 24, 2019, one hundred fifty million (150,000,000) Shares plus (D) effective upon April 20, 2021, one hundred fifteen million (115,000,000) Shares, plus (E) effective upon April 25, 2023, seventy-five million (75,000,000) Shares plus (F) effective upon April 24, 2024, one hundred million (100,000,000) Shares, plus (G) effective as of the date of stockholder approval during the 2025 annual meeting of the stockholders of the Company, one hundred million (100,000,000) Shares.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.2 Lapsed Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. If any Award is canceled, terminates, expires, or lapses for any reason, any Shares subject to such Award shall not count against the aggregate number of Shares available for grants under the Plan set forth in Section 4.1 above.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.3 Stock Options and SARs&#58; No Net Counting of Options or SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Counting of Shares Used to Pay Option Price and Withholding Taxes. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The full number of Shares with respect to which an Option or SAR is granted shall count against the aggregate number of Shares available for grant under the Plan. Accordingly, if in accordance with the terms of the Plan, a Participant pays the Option Price for an Option by either tendering previously owned Shares or having the Company withhold Shares, then such Shares surrendered to pay the Option Price shall continue to count against the aggregate number of Shares available for grant under the Plan set forth in Section 4.1 above. In addition, if in accordance with the terms of the Plan, a Participant satisfies any tax withholding requirement with respect to any taxable event arising as a result of this Plan with respect to an Award of Stock Options or SARs by either tendering previously owned Shares or having the Company withhold Shares, then such Shares surrendered to satisfy such tax withholding requirements shall continue to count against the aggregate number of Shares available for grant under the Plan set forth in Section 4.1 above.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.4 Restricted Stock and Restricted Stock Units&#58; Withholding Taxes.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> If in accordance with the terms of the Plan, a Participant satisfies any tax withholding requirement with respect to any taxable event arising as a result of this Plan with respect to an Award of Restricted Stock or Restricted Stock Units by having the Company withhold Shares, then such surrendered Shares shall again be available for the grant of future Awards under the Plan.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.5 Items Not Included</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The following items shall not count against the aggregate number of Shares available for grants under the Plan set forth in Section 4.1 above&#58; (a) the payment in cash of dividends or dividend equivalents under any outstanding Award&#59; (b) any Award that is settled in cash rather than by issuance of Shares&#59; or (c) Awards granted through the assumption of, or in substitution for, outstanding awards previously granted to individuals who become Employees as a result of a merger, consolidation, acquisition or other corporate transaction involving the Company or any Subsidiary.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.6 Award Limits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision herein to the contrary, the following provisions shall apply (subject to adjustment in accordance with Section 4.7 below)&#58;</font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)   the maximum number of each type of Award granted to any Participant in any calendar year shall not exceed the following number of Shares&#58; (i) Options and SARs&#58; four million (4,000,000) Shares&#59; and (ii) all Performance Awards (assuming maximum performance achievement)&#58; four million </font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font><br></font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font><br></font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font><br></font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4,000,000) Shares&#59; and</font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)   in no event shall there be granted during the term of the Plan Incentive Stock Options covering more than an aggregate of four hundred fifty million (450,000,000) Shares.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In addition, the maximum number of Shares subject to Award(s) granted to any Non-Employee Director during a calendar year, together with any cash fees paid during the calendar year to the Director, for the Non-Employee Director&#8217;s service during such year, shall not exceed one million dollars ($1,000,000) in total value (calculating the value of any such Awards based on the grant date Fair Market Value).  Notwithstanding the foregoing, this limit shall not include the value of charitable or </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">in memoriam</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> donations made by the Company on the Non-Employee Director&#8217;s behalf or fees paid, at the Board&#8217;s discretion, for service on any special purpose committee or for any other specific service, in each case provided that the Non-Employee Director receiving such additional compensation may not participate in the decision to award such compensation.</font></div><div><font><br></font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.7 Adjustments in Authorized Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event of any change in corporate capitalization, such as a stock split, or a corporate transaction, such as any merger, consolidation, separation, including a spin-off, or other distribution of stock or property of the Company (including a special cash dividend), any reorganization (whether or not such reorganization comes within the definition of such term in Code Section 368) or any partial or complete liquidation of the Company, or other transactions with similar impacts, such adjustment shall be made in the number and class of Shares which may be issued under the Plan and in the number and class of and&#47;or price of Shares subject to outstanding Awards granted under the Plan, as may be determined to be appropriate and equitable by the Committee, in its sole discretion, to prevent dilution or enlargement of rights&#59; provided, however, that (a) the number of Shares subject to any Award shall always be a whole number and (b) such adjustment shall be made in a manner consistent with the requirements of Code Section 409A in order for any Options or SARs to remain exempt from the requirements of Code Section 409A.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">4.8 Source of Shares</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Shares issued under the Plan may be original issue shares, treasury stock or shares purchased in the open market or otherwise, all as determined by the Chief Financial Officer of the Company (or the Chief Financial Officer&#8217;s designee) from time to time, unless otherwise determined by the Committee.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 5. Eligibility and Participation</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.1 Eligibility</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Persons eligible to participate in this Plan are all Employees of the Company, as determined by the Committee, including Employees who are Directors.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.2 Actual Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the provisions of the Plan, the Committee may, from time to time, select from all eligible Employees those to whom Awards shall be granted and shall determine the nature and amount of each Award. The grant of any Award to an eligible Employee is voluntary and occasional and does not create any contractual or other right to receive future Awards or benefits in lieu of Awards, even if such Awards have been granted in the past.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.3 Non-U.S. Employees</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision of the Plan to the contrary, in order to foster and promote achievement of the purposes of the Plan or to comply with provisions of laws in other countries in which the Company operates or has employees, the Committee, in its sole discretion, shall have the power and authority to (a) determine which Employees (if any) employed outside the United States are eligible to participate in the Plan, (b) modify the terms and conditions of any Awards made to such Employees and (c) establish subplans and modified Option exercise and other terms and procedures to the extent such actions may be necessary or advisable.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">5.4 Non-Employee Directors</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Non-Employee Directors may also participate in this Plan subject to the provisions set forth in Article 19 below.</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 6. Stock Options</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.1 Grant of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, Options may be granted to Employees in</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">such number, and upon such terms (including any performance conditions under Section 9.1), and at any time and from time to time as shall be determined by the Committee.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.2 Award Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Option grant shall be evidenced by an Award Agreement that shall specify the Option Price, the duration of the Option, the number of Shares to which the Option pertains, and such other provisions as the Committee shall determine. The Award Agreement also shall specify whether the Option is intended to be an ISO within the meaning of Section 422 of the Code, or an NQSO whose grant is intended not to fall under Code Section 422.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.3 Option Price</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Option Price for each grant of an Option under this Plan shall be at least equal to one hundred percent (100%) of the Fair Market Value of a Share on the date the Option is granted.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.4 Duration of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Option shall expire at such time as the Committee shall determine at the time of grant&#59; provided, however, that no Option shall be exercisable later than the tenth (10th) anniversary date of</font></div><div style="margin-bottom:5pt;text-indent:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">its grant.</font></div><div style="margin-bottom:5pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.5 Exercise of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Options granted under this Article 6 shall be exercisable at such times and be subject to such restrictions and conditions as the Committee shall in each instance approve and which shall be set forth in the applicable Award Agreement, which need not be the same for each grant or for each Participant.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.6 Payment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Options shall be exercised by the delivery of a notice of exercise to the Company, setting forth the number of Shares with respect to which the Option is to be exercised, accompanied by full payment for the Shares. To be effective, notice of exercise must be made in accordance with procedures established by the Company from time to time.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Option Price due upon exercise of any Option shall be payable to the Company in full either&#58; (a) in cash or its equivalent, or (b) by tendering previously acquired Shares having an aggregate Fair Market Value at the time of exercise equal to the total Option Price (provided that the Shares which are tendered must have been held by the Participant for at least six (6) months prior to their tender to satisfy the Option Price unless such Shares had been acquired by the Participant on the open market), or (c) by a combination of (a) and (b).</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As soon as practicable after notification of exercise and full payment, the Company shall deliver the Shares to the Participant in an appropriate amount based upon the number of Shares purchased under the Option(s).</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notwithstanding the foregoing, the Committee also may allow (a) cashless exercises as permitted under Federal Reserve Board&#8217;s Regulation T, subject to applicable securities law restrictions, or (b) exercises by any other means which the Committee determines to be consistent with the Plan&#8217;s purpose and applicable law.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.7 Restrictions on Share Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Committee may impose such restrictions on any Shares acquired pursuant to the exercise of an Option granted under this Article 6 as it may deem advisable, including, without limitation, restrictions under applicable Federal securities laws, under the requirements of any stock exchange or market upon which such Shares are then listed and&#47;or traded, and under any blue sky or state securities laws applicable to such Shares.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.8 Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each Participant&#8217;s Option Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the Option following termination of the Participant&#8217;s employment with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with Participants, need not be uniform among all Options issued pursuant to this Article 6, and may reflect distinctions based on the reasons</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">for termination of employment. In that regard, if an Award Agreement permits exercise of an Option following the death of the Participant, the Award Agreement shall provide that such Option shall be exercisable to the extent provided therein by any person that may be empowered to do so under the Participant&#8217;s will, or if the Participant shall fail to make a testamentary disposition of the Option or shall have died intestate, by the Participant&#8217;s executor or other legal representative.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.9 Nontransferability of Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Incentive Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No ISO granted under this Article 6 may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (including to, for the avoidance of doubt and without limiting the foregoing restrictions, third-party financial institutions), other than by will or by the laws of descent and distribution. Further, all ISOs granted to a Participant under the Plan shall be exercisable during his or her lifetime only by such Participant except to the extent otherwise permitted by applicable law.</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Nonqualified Stock Options</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise provided in a Participant&#8217;s Award Agreement, no NQSO granted under this Article 6 may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (including to, for the avoidance of doubt and without limiting the foregoing restrictions, third-party financial institutions), other than by will or by the laws of descent and distribution. Further, except as otherwise provided in a Participant&#8217;s Award Agreement, all NQSOs granted to a Participant under this Article 6 shall be exercisable during his or her lifetime only by such Participant. In no event may an NQSO be transferred for consideration.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.10 No Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant granted an Option shall have no rights as a stockholder of the Company with respect to the Shares covered by such Option except to the extent that Shares are issued to the Participant upon the due exercise of the Option.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">6.11 No Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In no event shall any Award of Options granted under the Plan include any dividend equivalents with respect to such Award.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 7. Stock Appreciation Rights</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.1 Grant of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the terms and conditions of the Plan, SARs may be granted to Employees at any time and from time to time as shall be determined by the Committee. The Committee shall have complete discretion in determining the number of SARs granted to each Participant (subject to Article 4 herein) and, consistent with the provisions of the Plan, in determining the terms and conditions pertaining to such SARs, including whether the SARs shall be subject to any performance conditions under Section 9.1. The grant price of an SAR shall be at least equal to the Fair Market Value of a Share on the date of grant of the SAR.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.2 Exercise of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. SARs may be exercised upon whatever terms and conditions the Committee, in its sole discretion, imposes upon them.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.3 SAR Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each SAR grant shall be evidenced by an Award Agreement that shall specify the grant price, the term of the SAR, and such other provisions as the Committee shall determine.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.4 Term of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The term of an SAR granted under the Plan shall be determined by the Committee, in its sole discretion&#59; provided, however, that such term shall not exceed ten (10) years.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.5 Payment of SAR Amount</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Upon exercise of an SAR, a Participant shall be entitled to receive payment from the Company in an amount determined by multiplying&#58;</font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)  The difference between the Fair Market Value of a Share on the date of exercise over the grant price&#59; by</font></div><div style="margin-bottom:10pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)  The number of Shares with respect to which the SAR is exercised.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">At the discretion of the Committee or as otherwise provided in the applicable Award Agreement, the payment upon SAR exercise shall be in cash, in Shares of equivalent value, or in some combination thereof.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.6 Other Restrictions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of the Plan, the Committee may impose such conditions on exercise of an SAR (including, without limitation, the right of the Committee to limit the time of exercise to specified periods) as may be required to satisfy the requirements of Section 16 (or any successor rule) of the Exchange Act or for any other purpose deemed appropriate by the Committee.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.7 Termination of Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each SAR Award Agreement shall set forth the extent to which the Participant shall have the right to exercise the SAR following termination of the Participant&#8217;s employment with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with Participants, need not be uniform among all SARs issued pursuant to the Plan, and may reflect distinctions based on the reasons for termination of employment. In that regard, if an Award Agreement permits exercise of an SAR following the death of the Participant, the Award Agreement shall provide that such SAR shall be exercisable to the extent provided therein by any person that may be empowered to do so under the Participant&#8217;s will, or if the Participant shall fail to make a testamentary disposition of the SAR or shall have died intestate, by the Participant&#8217;s executor or other legal representative.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.8 Nontransferability of SARs</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as otherwise provided in a Participant&#8217;s Award Agreement, no SAR granted under the Plan may be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated (including to, for the avoidance of doubt and without limiting the foregoing restrictions, third-party financial institutions), other than by will or by the laws of descent and distribution. Further, except as otherwise provided in a Participant&#8217;s Award Agreement, all SARs granted to a Participant under the Plan shall be exercisable during his or her lifetime only by such Participant. In no event may an SAR be transferred for consideration.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.9 No Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. A Participant granted an SAR shall have no rights as a stockholder of the Company with respect to the Shares covered by such SAR except to the extent that Shares are issued to the Participant upon the due exercise of the SAR.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">7.10 No Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In no event shall any Award of SARs granted under the Plan include any dividend equivalents with respect to such Award.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 8. Restricted Stock and Restricted Stock Units</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.1 Grant of Restricted Stock</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, the Committee, at any time and from time to time, may grant Shares of Restricted Stock or Restricted Stock Units to eligible Employees in such amounts as the Committee shall determine.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.2 Restricted Stock Agreement</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Each grant of Restricted Stock or Restricted Stock Units shall be evidenced by an Award Agreement that shall specify the Period or Periods of Restriction, the number of Shares of Restricted Stock or the number of Restricted Stock Units granted, and such other provisions as the Committee shall determine.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.3 Transferability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except as provided in this Article 8, the Shares of Restricted Stock or Restricted Stock Units granted herein may not be sold, transferred, pledged, assigned, or otherwise alienated or hypothecated </font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="margin-bottom:5pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">until the end of the applicable Period of Restriction established by the Committee and specified in the Award Agreement, or upon earlier satisfaction of any other conditions, as specified by the Committee in its sole discretion and set forth in the Award Agreement. All rights with respect to the Restricted Stock or Restricted Stock Units granted to a Participant under the Plan shall be available during his or her lifetime only to such Participant.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.4 Other Restrictions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee shall impose such other conditions and&#47;or restrictions on any Shares of Restricted Stock or Restricted Stock Units granted pursuant to the Plan as it may deem advisable including, without limitation, a requirement that Participants pay a stipulated purchase price for each Share of Restricted Stock or each Restricted Stock Unit, restrictions based upon the achievement of specific performance conditions under Section 9.1, time-based restrictions on vesting following the attainment of the performance goals, and&#47;or restrictions under applicable Federal or state securities laws. An Award of Shares of Restricted Stock or Restricted Stock Units may be intended to be a Performance Award that is subject to the provisions of Section 9.1.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall retain the Shares of Restricted Stock in the Company&#8217;s possession until such time as all conditions and&#47;or restrictions applicable to such Shares have been satisfied.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise provided in this Article 8, Shares of Restricted Stock covered by each Restricted Stock grant made under the Plan shall become freely transferable by the Participant after the last day of the Period of Restriction.</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.5 Settlement of Restricted Stock Units</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Any Restricted Stock Units that become payable in accordance with the terms and conditions of the applicable Award Agreement shall be settled in cash, Shares, or a combination of cash and Shares as determined by the Committee in its discretion or as otherwise provided for under the Award Agreement.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.6 Voting Rights</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Period of Restriction, Participants holding Shares of Restricted Stock granted hereunder may exercise full voting rights with respect to those Shares. There shall be no voting rights with respect to Restricted Stock Units.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.7 Dividends and Dividend Equivalents</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. During the Period of Restriction, Participants holding Shares of Restricted Stock granted hereunder may receive regular cash dividends paid with respect to the underlying Shares while the Restricted Stock is held by the Company. The Committee, in its discretion, may also grant dividend equivalents rights with respect to earned but unpaid Restricted Stock Units as evidenced by the applicable Award Agreement.  Dividends or dividend equivalents may be accrued as cash or reinvested in additional Shares or other securities of the Company at a price per unit equal to the Fair Market Value of a Share on the date that such dividend was paid to stockholders, as determined in the sole discretion of the Committee. Notwithstanding any provision herein to the contrary, in no event will a dividend or dividend equivalent become payable with respect to an Award that becomes vested (i) based on the satisfaction of performance criteria before the date, and only to the extent, that such performance criteria are satisfied, or (ii) based on continued service with the Company before the applicable vesting date.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">8.8 Termination of Employment. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Each Restricted Stock or Restricted Stock Unit Award Agreement shall set forth the extent to which the Participant shall have the right to receive unvested Restricted Shares or Restricted Stock Units following termination of the Participant&#8217;s employment with the Company and its Subsidiaries. Such provisions shall be determined in the sole discretion of the Committee, shall be included in the Award Agreement entered into with Participants, need not be uniform among all Shares of Restricted Stock or Restricted Stock Units issued pursuant to the Plan, and may reflect distinctions based on the reasons for termination of employment.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 9. Performance Measures</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.1 Performance Conditions. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The right of a Participant to exercise or receive a grant or settlement of any</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Award, and the timing thereof, may be subject to such performance conditions as may be specified by the Committee. The Committee may use such business criteria and other measures of performance as it may deem appropriate in establishing any such performance conditions.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.2 Performance Goals Generally. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The performance goals for Performance Awards shall consist of one or more business or other criteria and a targeted level or levels of performance with respect to each of such criteria, as specified by the Committee consistent with this Section 9.2. The Committee may determine that such Performance Awards shall be granted, exercised and&#47;or settled upon achievement of any one performance goal or that two or more of the performance goals must be achieved as a condition to grant, exercise, and&#47;or settlement of such Performance Awards. Performance goals may, in the discretion of the Committee, be established on a Company-wide basis, or with respect to one or more business units, divisions, subsidiaries, or business segments, as applicable. Performance goals may be absolute or relative (to the performance of one or more comparable companies or indices). The Committee may determine the extent to which measurement of performance goals may exclude the impact of charges for restructuring, discontinued operations, extraordinary items, debt redemption or retirement, asset write downs, litigation or claim judgments or settlements, acquisitions or divestitures, foreign exchange gains and losses, and other unusual non-recurring items, and the cumulative effects of tax or accounting changes (each as defined by generally accepted accounting principles and as identified in the Company&#8217;s financial statements or other SEC filings). Performance goals may differ for Performance Awards granted to any one Participant or to different Participants.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.3 Business Criteria. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of Performance Awards, the Committee may select any business criteria for the Company, on a consolidated basis, and&#47;or specified subsidiaries or business units of the Company, including any of the following&#58;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)          cash flow&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)         earnings per share&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)        income or other earnings measures&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)        return on equity, capital, assets, revenue or investments&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)         total stockholder return or other stock price performance measures&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)        stockholder value added&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)       revenue&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)      profit margin&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ix)        efficiency ratios&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(x)         customer satisfaction&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xi)        productivity&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xii)       expenses&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xiii)      balance sheet metrics, including capital ratios, liquidity measures and book value&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xiv)      credit quality&#59;</font></div><div style="text-indent:36.55pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xv)       strategic initiatives&#59; or</font></div><div style="text-indent:36.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(xvi)      implementation, completion or attainment of measurable objectives with respect to recruitment or</font></div><div style="margin-bottom:5pt;text-indent:36.95pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">              retention of personnel or employee satisfaction.</font></div><div style="text-indent:30.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The business criteria listed above shall include any derivations of such business criteria (e.g., income shall</font></div><div style="margin-bottom:5pt;text-indent:30.45pt"><font><br></font></div><div style="margin-bottom:5pt;text-indent:30.45pt"><font><br></font></div><div style="margin-bottom:5pt;text-indent:30.45pt"><font><br></font></div><div style="margin-bottom:5pt;text-indent:30.45pt"><font><br></font></div><div style="margin-bottom:5pt;text-indent:30.45pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt;text-indent:30.45pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">include pre-tax income, net income, operating income, etc.).</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">9.4. Written Determinations. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All determinations by the Committee as to the establishment of performance</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">goals, the amount of any potential individual Performance Awards and the achievement of performance goals relating to Performance Awards, shall be made in writing. The Committee may delegate any responsibility relating to such Performance Awards.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 10. Beneficiary Designation</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Except as otherwise provided in an Award Agreement, each Participant under the Plan may, from time to time, name any beneficiary or beneficiaries (who may be named contingently or successively) to whom any benefit under the Plan is to be paid in case of his or her death before he or she receives any or all of such benefit. Each such designation shall revoke all prior designations by the same Participant, shall be in a form and pursuant to such procedures as may be prescribed by the Company, and will be effective only when filed by the Participant in writing with the Company during the Participant&#8217;s lifetime. In the absence of any such designation, benefits remaining unpaid at the Participant&#8217;s death shall be paid to the Participant&#8217;s estate.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 11. Deferrals</font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Committee may permit a Participant to defer such Participant&#8217;s receipt of the payment of cash or the delivery of Shares that would otherwise be due to such Participant by virtue of the exercise of an Option or SAR or the lapse or waiver of restrictions with respect to Restricted Stock or Restricted Stock Units, to the extent permitted by Section 409A of the Code (if applicable). If any such deferral election is required or permitted, the Committee shall, in its sole discretion, establish rules and procedures for such payment deferrals. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 12. Rights of Employees</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.1 Employment</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Nothing in the Plan shall interfere with or limit in any way the right of the Company to terminate any Participant&#8217;s employment at any time, nor confer upon any Participant any right to continue in the employ of the Company.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of this Plan, a transfer of a Participant&#8217;s employment between the Company and a Subsidiary, or between Subsidiaries, shall not be deemed to be a termination of employment. Upon such a transfer, the Committee may make such adjustments to outstanding Awards as it deems appropriate to reflect the changed reporting relationships.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">12.2 Participation</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No Employee shall have the right to be selected to receive an Award under this Plan, or, having been so selected, to be selected to receive a future Award or a future Award in any specified amount.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 13. Change in Control</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.1 Treatment of Outstanding Awards. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless otherwise specifically prohibited under applicable laws, or by the rules and regulations of any governing governmental agencies or national securities exchanges, the Committee may, in its sole discretion, at the time an Award is made hereunder or at any time prior to, coincident with or after the time of a Change in Control take any one or more of the following actions which shall apply only upon the occurrence of a Change in Control or, if later, upon the action being taken&#58;</font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)  provide for the acceleration of any time periods, or the waiver of any other conditions, relating to the vesting, exercise, payment or distribution of an Award so that any Award to a Participant whose employment has been terminated as a result of a Change in Control may be vested, exercised, paid </font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font><br></font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or distributed in full on or before a date fixed by the Committee, and in connection therewith the Committee may (i) provide for an extended period to exercise Options (not to exceed the original Option term) and </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(ii) determine the level of attainment of any applicable performance goals&#59;</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)  provide for the purchase of any Awards from a Participant whose employment has been terminated as a result of a Change in Control, upon the Participant&#8217;s request, for an amount of cash equal to the amount that could have been obtained upon the exercise, payment or distribution of such rights had such Award been currently exercisable or payable&#59; or</font></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)  cause the Awards then outstanding to be assumed, or new rights substituted therefore, by the surviving corporation in such Change in Control.</font></div><div><font><br></font></div><div style="margin-bottom:15pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For purposes of sub-paragraphs (a) and (b) above, any Participant whose employment is either (i) terminated by the Company other than for &#8220;cause,&#8221; or (ii) terminated by the Participant for &#8220;good reason&#8221; (each as defined in the applicable Award Agreement), in either case upon, or on or prior to the second anniversary of, a Change in Control, shall be deemed to have been terminated as a result of the Change in Control.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.2 Limitation on Change-in-Control Benefits</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. It is the intention of the Company and the Participants to reduce the amounts payable or distributable to a Participant hereunder if the aggregate Net After Tax Receipts (as defined below) to the Participant would thereby be increased, as a result of the application of the excise tax provisions of Section 4999 of the Code. Accordingly, anything in this Plan to the contrary notwithstanding, in the event that the certified public accountants regularly employed by the Company immediately prior to any &#8220;change&#8221; described below (the &#8220;Accounting Firm&#8221;) shall determine that receipt of all Payments (as defined below) would subject the Participant to tax under Section 4999 of the Code, it shall determine whether some amount of Payments would meet the definition of a &#8220;Reduced Amount&#8221; (as defined below). If the Accounting </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Firm determines that there is a Reduced Amount, the aggregate Payments shall be reduced to such Reduced Amount in accordance with the provisions of Section 13.2(b) below.</font></div><div style="margin-bottom:5pt;text-indent:37.65pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a) For purposes of this Section 13.2(a)&#58;</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i) A &#8220;Payment&#8221; shall mean any payment or distribution in the nature of compensation to or for the benefit of a Participant who is a &#8220;disqualified individual&#8221; within the meaning of Section 280G(c) of the Code and which is contingent on a &#8220;change&#8221; described in Section 280G(b)(2)(A)(i) of the Code with respect to the Company, whether paid or payable pursuant to this Plan or otherwise&#59;</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)  &#8220;Plan Payment&#8221; shall mean a Payment paid or payable pursuant to this Plan (disregarding this Section 13.2)&#59;</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)  &#8220;Net After Tax Receipt&#8221; shall mean the Present Value of a Payment, net of all taxes imposed on the Participant with respect thereto under Sections 1 and 4999 of the Code, determined by applying the highest marginal rate under Section 1 of the Code which applied to the Participant&#8217;s Federal taxable income for the immediately preceding taxable year&#59;</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv) &#8220;Present Value&#8221; shall mean such value determined in accordance with Section 280G(d)(4) of the Code&#59; and</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v) &#8220;Reduced Amount&#8221; shall mean the smallest aggregate amount of Payments which (A) is less than the sum of all Payments and (B) results in aggregate Net After Tax Receipts which are equal to or greater than the Net After Tax Receipts which would result if all Payments were paid to or for the benefit of the Participant.</font></div><div style="padding-left:54.72pt;padding-right:15.84pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)  If the Accounting Firm determines that aggregate Payments should be reduced to the Reduced Amount, the Committee shall promptly give the Participant notice to that effect and a copy of the detailed calculation thereof. The Company shall reduce or eliminate the Payments, by first reducing </font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="padding-left:54.72pt;padding-right:15.84pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or eliminating the portion of the Payments which are not payable in cash and then by reducing or eliminating cash payments, in each case in reverse order beginning with payments or benefits which are to be paid the farthest in time from the determination, all as determined by the Accounting Firm. All determinations made by the Accounting Firm under this Section 13.2 shall be binding upon the</font></div><div style="margin-bottom:5pt;padding-left:54.72pt;padding-right:15.84pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">      Company and the Participant and shall be made within sixty (60) days immediately following the event constituting the &#8220;change&#8221; referred to above. As promptly as practicable following such determination, the Company shall pay to or distribute for the benefit of the Participant such Payments as are then due to the Participant under this Plan.</font></div><div style="margin-bottom:10pt;padding-left:54.72pt;padding-right:15.84pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)  At the time of the initial determination by the Accounting Firm hereunder, it is possible that amounts will have been paid or distributed by the Company to or for the benefit of the Participant pursuant to this Plan which should not have been so paid or distributed (&#8220;Overpayment&#8221;) or that additional amounts which will have not been paid or distributed by the Company to or for the benefit of the Participant pursuant to this Plan could have been so paid or distributed (&#8220;Underpayment&#8221;), in each case, consistent with the calculation of the Reduced Amount hereunder. In the event that the Accounting Firm, based either upon the assertion of a deficiency by the Internal Revenue Service against the Company or the Participant which the Accounting Firm believes has a high probability of success or controlling precedent or other substantial authority, determines that an Overpayment has been made, any such Overpayment paid or distributed by the Company to or for the benefit of the Participant shall be treated for all purposes as a loan ab initio to the Participant which the Participant shall repay to the Company together with interest at the applicable Federal rate provided for in Section 7872(f)(2) of the Code&#59; provided, however, that no such loan shall be deemed to have been made and no amount shall be payable by the Participant to the Company if and to the extent (i) such deemed loan and payment would not either reduce the amount on which the Participant is subject to tax under Section 1 and Section 4999 of the Code or generate a refund of such taxes or (ii) the Participant is subject to the prohibition on personal loans under Section 402 of the Sarbanes-Oxley Act of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">2002. In the event that the Accounting Firm, based upon controlling precedent or other substantial authority, determines that an Underpayment has occurred, any such Underpayment shall be promptly paid by the Company to or for the benefit of the Participant together with interest at the applicable Federal rate provided for in Section 7872(f)(2) of the Code.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">13.3 Termination, Amendment, and Modifications of Change-in-Control Provisions</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any other provision of this Plan or any Award Agreement provision, the provisions of this Article 13 may not be terminated, amended, or modified on or after the date of a Change in Control to affect adversely any Award theretofore granted under the Plan without the prior written consent of the Participant with respect to said Participant&#8217;s outstanding Awards&#59; provided, however, the Board of Directors, upon recommendation of the Committee, may terminate, amend, or modify this Article 13 at any time and from time to time prior to the date of a Change in Control.</font></div><div><font><br></font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 14. Amendment, Modification, and Termination</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.1 Amendment, Modification, and Termination</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Board may at any time and from time to time, alter, amend, suspend or terminate the Plan in whole or in part&#59; provided, however, that an amendment to the Plan may be conditioned on the approval of the stockholders of the Company if and to the extent the Board determines that stockholder approval is necessary or appropriate.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.2 Awards Previously Granted</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. No termination, amendment, or modification of the Plan shall adversely affect in any material way any Award previously granted under the Plan, without the written consent of the Participant holding such Award.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">14.3 No Repricing</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision herein to the contrary, the repricing of Options or SARs is </font></div><div style="text-indent:6pt"><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prohibited without prior approval of the Company&#8217;s stockholders. For this purpose, a &#8220;repricing&#8221; means any of the following (or any other action that has the same effect as any of the following)&#58; (A) changing the terms of an Option or SAR to lower its Option Price or grant price&#59; (B) any other action that is treated as a &#8220;repricing&#8221; under generally accepted accounting principles&#59; and (C) repurchasing for cash or canceling an Option or SAR at</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">a time when its Option Price or grant price is greater than the Fair Market Value of the underlying Shares in exchange for another Award, unless the cancellation and exchange occurs in connection with a change in capitalization or similar change under Section 4.7 above. Such cancellation and exchange would be considered a &#8220;repricing&#8221; regardless of whether it is treated as a &#8220;repricing&#8221; under generally accepted accounting principles and regardless of whether it is voluntary on the part of the Participant.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 15. Withholding</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.1 Tax Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company shall have the power and the right to deduct or withhold, or require a Participant to remit to the Company, an amount sufficient to satisfy Federal, state, local, foreign or other taxes (including the Participant&#8217;s FICA or other applicable social tax obligation) required by law to be withheld with respect to any taxable event arising as a result of this Plan.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">15.2 Share Withholding</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Company may cause any tax withholding obligation described in Section 15.1 to be satisfied by the Company withholding Shares having a fair market value on the date the tax is to be determined equal to the required tax withholding imposed on the transaction (not to exceed maximum statutory rates). In the alternative, the Company may permit Participants to elect to satisfy the tax withholding obligation, in whole or in part, by either (a) having the Company withhold Shares having a fair market value on the date the tax is to be determined equal to the required tax withholding imposed on the transaction (not to exceed maximum statutory rates) or (b) tendering previously acquired Shares having an aggregate fair market value equal to the required tax withholding imposed on the transaction (not to exceed maximum statutory rates). All such elections shall be irrevocable, made in writing, signed by the Participant, and shall be subject to any restrictions or limitations that the Committee, in its sole discretion, deems appropriate.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 16. Indemnification</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Provisions for the indemnification of officers and directors of the Company in connection with the administration of the Plan shall be as set forth in the Company&#8217;s Certificate of Incorporation and Bylaws as in effect from time to time.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 17. Successors</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">All obligations of the Company under the Plan with respect to Awards granted hereunder shall be binding on any successor to the Company, whether the existence of such successor is the result of a direct or indirect purchase, merger, consolidation, or otherwise, of all or substantially all of the business and&#47;or assets of the Company.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 18. Legal Construction</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.1   Gender and Number</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Except where otherwise indicated by the context, any masculine term used herein also shall include the feminine&#59; the plural shall include the singular and the singular shall include the plural.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.2   Severability</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. In the event any provision of the Plan shall be held illegal or invalid for any reason, the illegality or invalidity shall not affect the remaining parts of the Plan, and the Plan shall be construed and enforced as if the illegal or invalid provision had not been included.</font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.3   Requirements of Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The granting of Awards and the issuance of Shares under the Plan shall be subject to all applicable laws, rules, and regulations, and to such approvals by any governmental agencies or national securities exchanges as may be required.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.4   Securities Law Compliance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. With respect to Insiders, transactions under this Plan are intended to comply with all applicable conditions of Rule 16b-3 or its successors under the Exchange Act. To the extent any provision of the plan or action by the Committee fails to so comply, it shall be deemed null and void, to the extent permitted by law and deemed advisable by the Committee.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.5   No Conflict</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Unless otherwise provided for by an Award Agreement, in the event of any conflict between the terms of the Plan and the terms of an Award Agreement, the terms of the Plan shall control.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.6   Governing Law</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. To the extent not preempted by Federal law, the Plan, and all agreements hereunder, shall be construed in accordance with and governed by the laws of the State of Delaware.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">18.7   Compliance With Code Section 409A</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Plan is intended to comply with Code Section 409A, to the extent applicable. Notwithstanding any provision of the Plan to the contrary, the Plan shall be interpreted, operated and administered consistent with this intent. In that regard, and notwithstanding any provision of the Plan to the contrary, the Company reserves the right to amend the Plan or any Award granted under the Plan, by action of the Committee, without the consent of any affected Participant, to the extent deemed necessary or appropriate for purposes of maintaining compliance with Code Section 409A.</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Article 19. Non-Employee Directors</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.1 Restricted Stock Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Subject to the terms and provisions of the Plan, including the annual award limit for Non-Employee Directors set forth in Section 4.6, the Board, at any time and from time to time, may grant Shares of Restricted Stock to Non-Employee Directors in such amounts as the Board shall determine. Notwithstanding the definition of &#8220;Participant&#8221; provided in Article 2 above, upon receipt of a grant of Shares of Restricted Stock, a Non-Employee Director shall be considered a Participant in the Plan. Each grant of Shares of Restricted Stock to a Non-Employee Director shall be evidenced by an Award Agreement that shall specify the Period or Periods of Restriction, the number of Shares of Restricted Stock granted, and such other provisions as the Board shall determine.</font></div><div style="margin-bottom:5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.2 Administration</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. The Board shall be responsible for administering any grants of Restricted Stock to Non- Employee Directors and shall have all of the powers necessary to enable it to properly carry out its duties hereunder. Not in limitation of the foregoing, the Board shall have the power to construe and interpret the Plan and to determine all questions that shall arise thereunder with respect to grants of Restricted Stock to Non- Employee Directors. The Board shall have such other and further specified duties, powers, authority and discretion as are elsewhere in the Plan either expressly or by necessary implication conferred upon it. The Board may appoint such agents as it may deem necessary for the effective performance of its duties, and may delegate to such agents such powers and duties as the Board may deem expedient or appropriate that are not inconsistent with the intent of the Plan and this Article 19. The decision of the Board upon all matters within the scope of authority shall be final and conclusive on all persons, except to the extent otherwise provided by law.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.3 Vesting</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. Notwithstanding any provision of the Plan to the contrary, Shares of Restricted Stock granted to Non-Employee Directors shall not become vested until the first anniversary of the applicable date of grant (or, if earlier, the date of the next annual meeting of the stockholders of the Company) (the &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Non-Employee Director Vesting Date</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), provided that if the Non-Employee Director Vesting Date occurs less than 50 weeks after the applicable date of grant, it shall count against the 5% exception pool to the minimum vesting requirements set forth in Section 3.4. If the Non-Employee Director ceases to serve as a Non-Employee Director before the Non- Employee Director Vesting Date due to the Non-Employee Director&#8217;s death, or if there is a Change in Control</font></div><div><font><br></font></div><div><font><br></font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</font></div></div></div><hr style="page-break-after:always"><div style="min-height:46.08pt;width:100%"><div style="text-align:right"><font><br></font></div><div style="text-align:right"><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">prior to the Vesting Date, then the Shares shall become fully vested as of the date of such death or Change in Control, as applicable. If the Non-Employee Director ceases to serve as a Non-Employee Director at any time for any reason other than death before the earlier of the Vesting Date or a Change in Control, then the Shares shall become vested pro rata (based on the number of days between the grant date of the Shares of Restricted</font></div><div style="margin-bottom:10pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Stock, or in the case of Shares of Restricted Stock granted to a newly appointed Non-Employee Director, the date of commencement of services, and the date of cessation of services divided by (a) 365 days for grants made at an annual stockholders meeting or (b) the number of days from the date of commencement of services until the next annual stockholders meeting for grants made to a newly appointed Non-Employee Director), and to the extent the Shares are not thereby vested they shall be forfeited as of the date of such cessation of services. A Non-Employee Director may not sell, transfer or otherwise dispose of any Shares of Restricted Stock until they become vested&#59; however, the Non-Employee Director shall have the right to receive dividends with respect to the Shares, subject to the terms and conditions of Section 8.7, and to vote the Shares prior to vesting. If a Non-Employee Director has elected to defer any Shares of Restricted Stock pursuant to the Bank of America Corporation Director Deferral Plan (or any other similar plan in which the Non-Employee Director participates, including any successor or replacement plan) (a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Deferral Plan</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221;), then (i) such Shares shall not be issued under this Plan, (ii) the Non-Employee Director shall be credited with &#8220;Stock Units&#8221; to be paid in cash when and as provided for under the Deferral Plan, and (iii) the vesting provisions set forth above shall apply to any such Shares that are deferred as Stock Units under the Deferral Plan.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">19.4 No Other Awards</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">. For purposes of clarity, Non-Employee Directors may not receive any other form of Award described in this Plan, other than grants of Shares of Restricted Stock.</font></div><div style="height:12.96pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ic38eebf5013e4d36ad6230d7aa03fb1b_41"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 99.1</font></div></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:18pt;font-weight:400;line-height:120%">Proposal 4&#58; Proposal to amend and restate the Bank of America Corporation Equity Plan </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Executive summary </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Proposal 4 seeks to amend and restate the Bank of America Corporation Equity Plan (BACEP or Plan) to (i) increase the number of shares available for grant by 100 million&#59; (ii) limit the value of shares granted to a non-employee director in a calendar year, together with any cash fees paid during the calendar year, to $1 million in total value, with certain donation and special service exceptions&#59; and (iii) extend the expiration date of the Plan. </font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Equity-based awards are a fundamental part of how we align compensation with our shareholders&#8217; interests, and the BACEP plays a critical role in our pay-for-performance compensation program and in our compliance with regulatory requirements. During our extensive engagement efforts in 2024, shareholders expressed support for our unique broad use of equity awards and understood how this practice contributes to burn rate. </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Compensation and Human Capital Committee exercises oversight of our compensation program and employee benefits, including the intentional granting of shares under the BACEP, taking into account broader company, human capital, and capital allocation strategy to support our teammates, deliver a world-class experience for clients and Responsible Growth for shareholders. </font></td></tr></table></div><div style="margin-top:11pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Material changes </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The amendment and restatement makes the following material changes&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The number of shares of our common stock available for awards under the Plan will be increased by 100 million. In 2024, shareholders approved the addition of 100 million shares for grant under the Plan, and the company awarded approximately 117.4 million in the same year. The additional 100 million shares requested would allow the company to continue current grant practices for at least one more year. </font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Plan limits the maximum number of shares subject to awards granted to a non-employee director in a calendar year, together with any cash fees paid during the calendar year to that director, to $1 million in total value, excluding charitable or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">in memoriam </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">donations made by the company and fees paid, at the Board&#8217;s discretion, for service on any special purpose committee or for any other specific service. </font></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.600%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.460%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The Plan term is extended through April 21, 2035 (i.e., 10 years after the date of the annual meeting). </font></td></tr></table></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Background </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP was last amended and approved by shareholders in 2024, which included the addition of 100 million shares available for grant. Under the Plan, we have reserved a number of shares of our common stock for issuance to employees (including executive officers) as equity-based awards in the form of restricted stock, restricted stock units (RSUs), stock options, and SARs and for issuance to non-employee directors as restricted stock awards. The BACEP is currently scheduled to expire on April 24, 2033. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In March 2025, our Board approved the amendment and restatement of the BACEP to increase the number of common shares available to grant, limit the maximum number of shares annually awarded to directors, and extend the term of the Plan to April 2035, subject to the approval of our shareholders at the annual meeting. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Based on data available as of December 31, 2024, our level of overhang was lower than the average for our primary competitor group. Additionally, our rate at which we grant equity awards relative to shares of our common stock outstanding (sometimes referred to as &#8220;burn rate&#8221;) was below the average burn rate for our primary competitor group on a three-year average basis. If the proposed amendment and restatement is approved, we expect the pool of requested shares to last approximately one year, assuming we maintain similar grant practices as over the past two years and assuming, hypothetically, our current stock price remains constant. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of shares remaining available for grant under the BACEP as noted in the table below differs from those reported as of December 31, 2024, because that information does not take into account year-to-date grants during 2025 for the 2024 performance year. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Information regarding the number of shares remaining available for grant as required by SEC disclosure rules are discussed in detail in this proposal under &#8220;Additional information&#8221; on page 88. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The list of companies included in our primary competitor group is detailed under &#8220;2024 Competitor group&#8221; on page 64. </font></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Impact of the amendment and restatement based on information as of March 3, 2025 </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">As of March 3, 2025, under the current authorization, there are approximately 85 million shares of common stock available for grant as equity- based awards under the BACEP. Based on our current grant practices, these shares would last less than one year, while the current BACEP term has eight years remaining. We believe it is appropriate to increase the number of shares of our common stock available for awards under the BACEP so that our company can continue the practice of granting deferred equity-based awards in lieu of cash. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">We estimate the total dilutive effect of the BACEP and our legacy stock plans on our shareholders (sometimes called &#8220;overhang&#8221;) resulting from the amendment and restatement would be approximately 6.0%, with the incremental overhang resulting from the requested share increase equal to approximately 1.2%. The overhang is calculated as follows, in each case as of March 3, 2025&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:78.867%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.329%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.404%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(a) Incremental share request subject to shareholder approval</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">100,000,000</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(b) Shares underlying outstanding awards of restricted shares &#47; stock-settled restricted stock units under all equity plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">299,219,789</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(c) Options outstanding under all equity plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">0</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(d) Shares currently available for future issuance under all equity plans</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">84,942,478</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(e) Total shares available for, or outstanding under, equity awards (a + b + c + d)</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">484,162,267</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(f) Total common shares outstanding</font></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,602,798,325</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:0 1pt"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:1.37pt;padding-right:-2.63pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(g) Fully diluted overhang (e&#47;(e+f))</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:400;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.0</font></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="6" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #022169;padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(h) Basic diluted overhang (e&#47;f)</font></td><td colspan="3" style="border-bottom:1pt solid #022169;padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6.4</font></td><td colspan="3" style="border-bottom:1pt solid #022169;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.562%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.138%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes 7,080,018 vested RSUs subject to a required six- or twelve-month holding period and 753,102 vested RSUs that are expected to be issued&#47;delivered within 30 days of the record date. Also includes 394,932 vested RSUs and stock option gain deferrals that were assumed by the company in connection with prior acquisitions under whose plans the awards were originally granted. This total includes PRSUs vesting at target (the target amount, 100%, is the maximum that can be earned). </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">The total number of non-compensatory warrants and convertible instruments as of March 3, 2025 was 61,603,640, and is not reflected in the table above. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Includes 84,942,478 shares of common stock available for future issuance under the BACEP. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:justify;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">To determine the sum of (e) plus (f) for this calculation, 33,289 restricted stock shares included in both (e) and (f) are counted only once to prevent duplicative aggregation. </font></td></tr></table><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Purpose of the Plan </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Plan, and the proposed amendment and restatement of it, is intended to serve a critical role in our pay-for-performance compensation program and is necessary for us to comply with the regulatory landscape in certain jurisdictions. In addition, our Board believes that equity-based awards aid in our ability to attract, retain, and motivate our employees and are the most direct way to align employee interests with those of shareholders. As part of our pay-for-performance practices, more than 100,000 employees receive variable incentives. More highly compensated employees receive a portion of their variable incentive as deferred RSUs. The portion of the variable incentive deferred as equity-based awards generally increases with compensation levels according to a predetermined deferral grid. RSUs are also a significant component of the Sharing Success awards that have been or will be made to approximately 97% of employees in March 2025. Most Sharing Success awards are in the form of company common stock, providing the opportunity to further share in our company&#8217;s long-term success. The RSU awards are a key part of our pay-for-performance philosophy, and in many cases are required by law, rule, and regulation. In addition, our executive officers receive PRSUs that must be re-earned by meeting specific performance criteria, as described on page 60 for awards granted in February 2025. Equity awards granted to employees are subject to cancellation and clawback features which encourage appropriate behavior and manage risk in our compensation program&#59; these features are described on page 62. Granting RSU awards that include deferral, cancellation, and clawback features is </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">a key risk-balancing mechanism in our pay-for-performance compensation program and serves to align employee interests with shareholder interests while complying with regulatory requirements. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The value of RSUs tracks the price of our common shares. Compensation expense is in the compensation and benefits expense line of the income statement. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Plan, and the proposed amendment and restatement of it, is intended to be the company&#8217;s vehicle for delivering deferred equity-based awards. Since April 2022, the amount of common stock awarded has averaged approximately 111 million shares each year, which includes approximately 19.2 million shares granted in March 2025 under the Sharing Success award program leaving approximately 85 million shares remaining for future awards. The Board has determined to increase the shares of our common stock available for awards under the Plan by 100 million shares to enable the granting of Plan awards in the future. The alternative would be to increase the use of deferred cash awards, which we believe would reduce alignment with shareholder interests. Therefore, the Board recommends the amendment and restatement to increase the number of shares of common stock available for awards under the Plan. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In addition, the company has and continues to repurchase shares of common stock in an amount at least equal to the value of stock-settled equity awards as they are recognized into capital. These share repurchases offset the net new shares of common stock delivered under the BACEP. The company currently intends to continue this repurchase practice. The company&#8217;s common stock repurchases are subject to required regulatory review and Board approval. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The additional 100 million shares to be authorized under the BACEP would allow our company to continue current grant practices for approximately one year. </font></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Overview of the amendment and restatement </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following is a summary of the material terms of the proposed amendment and restatement and is qualified, in its entirety, by reference to the terms of the BACEP. A copy of the BACEP, approved by the Board in March 2025, is attached to this proxy statement as Appendix B. There are no proposed changes to the shareholder-friendly design features of the Plan, summarized on page 82, except that the proposed amendment and restatement adds a new annual award limit for non-employee directors. The proposed amendment and restatement will become effective only if the BACEP is approved by our shareholders. </font></div><div style="margin-top:10pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Number of shares </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP, as last approved by shareholders in 2024, provides that the aggregate number of shares of our common stock available for grants of awards under the Plan from and after January 1, 2015 will not exceed the sum of (i) 450 million shares, plus (ii) any shares that were subject to an award as of December 31, 2014 under the BACEP, if such award is canceled, terminates, expires, lapses or is settled in cash for any reason from and after January 1, 2015, plus (iii) effective upon April 24, 2019, 150 million shares, plus (iv) effective upon April 20, 2021, 115 million shares, plus (v) effective upon April 25, 2023, 75 million shares, plus (vi) effective upon April 24, 2024, 100 million shares. As of March 3, 2025, there were approximately 85 million common shares available for future awards under the BACEP. The amendment and restatement, if approved by shareholders, would increase the number of shares available for awards by 100 million shares, to approximately 185 million shares estimated based on information available on March 3, 2025. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Under the BACEP, each award, whether granted as a stock option, SAR, restricted stock share or RSU, counts against the available share pool as one share for each share awarded. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The share re-use provisions under the BACEP do not include any &#8220;liberal share counting&#8221; features for stock options or SARs. Shares used to cover the exercise price of stock options or to cover any tax withholding obligations in connection with awards of stock options or SARs will continue to be unavailable for awards under the BACEP. In addition, the total number of shares covering stock-settled SARs or net-settled options will be counted against the pool of available shares, not just the net shares issued upon exercise. The BACEP does allow shares withheld to cover any tax withholding obligations in connection with awards of restricted stock or RSUs to again be available for future awards under the BACEP. Shares covered by awards will also continue to be available for awards if and to the extent (a) the award is canceled or forfeited or (b) the award is settled in cash. </font></div><div style="margin-top:10pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Administration </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Compensation and Human Capital Committee (Committee) administers the BACEP. To the extent permitted by law, the Committee may designate an individual or committee (which need not consist of directors) to act as the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">appropriate committee under the BACEP for granting awards to employees who are not &#8220;officers&#8221; under Section 16 of the Exchange Act. Under the BACEP, the Committee has authority with respect to the following&#58; </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.760%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.660%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">the selection of the employees to receive awards from time to time </font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:1.080%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.020%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">the granting of awards in amounts as it determines </font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.077%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.665%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">the imposition of limitations, restrictions, and conditions upon awards </font></td></tr></table><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.077%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.758%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.665%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">the certification of the attainment of performance goals, if applicable </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">the interpretation of the BACEP and the adoption, amendment and rescission of administrative guidelines and other rules and regulations relating to the BACEP </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">the correction of any defect or omission or reconciliation of any inconsistency in the BACEP or any award granted under the BACEP </font></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">the making of all other determinations and taking of all other actions necessary or advisable for the implementation and administration of the BACEP </font></td></tr></table></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The Board will continue to administer grants of restricted stock under the BACEP to non-employee directors. </font></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Eligibility </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Employees of Bank of America and its subsidiaries may participate in the BACEP, as selected by the Committee. Eligible employees are those employees of Bank of America and its subsidiaries who have made, or are expected to make, important contributions to our business, as determined by the Committee, including persons employed outside the United States. Approximately 196,000 employees are expected to be eligible to participate. However, as mentioned above, the Committee in its discretion selects which employees will receive any awards. The BACEP also provides for awards of restricted stock to non-employee directors as part of our director compensation program. All 13 of the non-employee directors nominated for election at the annual meeting are eligible to receive these restricted stock awards. As noted elsewhere in this proxy statement, as part of our director compensation program, our Board grants restricted stock to directors on the day of their election or appointment as a director. Any director nominee that receives at least a majority of votes cast at the annual meeting will be elected at the annual meeting and will be eligible to receive the restricted stock award as part of their 2025-2026 director compensation. In the event this proposed amendment and restatement does not receive at least a majority of the votes cast at the annual meeting, and the amendment and restatement does not become effective, there are enough common shares remaining for issuance to grant directors elected at the annual meeting the 2025-2026 restricted stock award. </font></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Types of awards </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP permits awards of stock options, SARs, restricted stock shares and RSUs to employees and restricted stock shares to non-employee directors, all of which are described in more detail below. </font></div><div style="margin-top:5pt"><font style="color:#cf0a2c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Awards of stock options and SARs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> The BACEP provides for the grant of options to purchase shares of our common stock at option prices which are not less than the fair market value of a share of our common stock at the close of business on the date of grant. (The fair market value of a share of our common stock as of March 3, 2025, was $45.56.) The BACEP also provides for the grant of SARs to employees. SARs entitle the holder upon exercise to receive either cash or shares of our common stock or a combination of the two, as the Committee in its discretion may determine, with a value equal to the difference between&#58; (i) the fair market value on the exercise date of the shares with respect to which a SAR is exercised&#59; and (ii) the fair market value of the shares on the date of grant. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Awards of options under the BACEP, which may be either incentive stock options (which qualify for special tax treatment) or nonqualified stock options, are determined by the Committee. No more than an aggregate of 450 million shares may be awarded as incentive stock options under the BACEP. The terms and conditions of each option and SAR are to be determined by the Committee (or its designees) at the time of grant. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Options and SARs granted under the BACEP will expire not more than 10 years from the date of grant, and the award agreements entered into with each participant will specify the extent to which options and SARs may be exercised during their respective terms, including in the event of the participant&#8217;s death, disability, or termination of employment. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP includes two additional limitations on stock option and SAR grants. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.758%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.144%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">The BACEP expressly prohibits dividend equivalents with respect to stock options and SARs. </font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:0.598%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.438%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:97.464%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#022169;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8226;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Unless otherwise provided in an award agreement, the BACEP prohibits the sale, transfer, pledge, assignment, or other alienation or hypothecation (including to, for the avoidance of doubt and without limiting the foregoing restrictions, third-party financial institutions) of nonqualified stock options and SARS. </font></td></tr></table></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Board has not granted stock options or SARs since 2008. </font></div><div style="margin-top:5pt"><font style="color:#cf0a2c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Awards of restricted stock shares and RSUs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> Under the BACEP, the Committee may award employees restricted shares of our common stock or RSUs which represent the right to receive shares of our common stock (or cash equal to the fair market value of those shares). Each award agreement will contain the terms of the award, including any applicable conditions, which may include continued service of the participant, the attainment of specified performance goals or any other conditions deemed appropriate by the Committee. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Restricted stock shares will be held in our custody until the applicable restrictions have been satisfied. The participant cannot sell, transfer, pledge, assign, or otherwise alienate or hypothecate (including to, for the avoidance of doubt and without limiting the foregoing restrictions, third-party financial institutions) restricted stock shares until the applicable restrictions are satisfied. Once the restrictions are satisfied, the shares will be delivered to the participant&#8217;s account, free of restrictions. During the period of restriction, the participant may exercise full voting rights with respect to the restricted stock shares. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The award agreement for any RSUs will specify whether units that become earned and payable will be settled in shares of our common stock (with one share of common stock to be delivered for each earned and payable RSU), in cash (equal to the aggregate fair market value of the RSUs that are earned and payable), or in a combination of shares and cash. Shares of our common stock used to pay earned RSUs may have additional restrictions, as determined by the Committee. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP also provides for awards of restricted stock shares to our non-employee directors as part of our director compensation program. The amended and restated BACEP, if approved by shareholders, limits the maximum number of shares subject to awards granted to a non-employee director in a calendar year, together with any cash fees paid during the calendar year to that director, to $1 million in total value, excluding charitable or </font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-style:italic;font-weight:400;line-height:120%">in memoriam</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> donations made by the company and fees paid, at the Board&#8217;s discretion, for service on any special purpose committee or for any other specific service. Some of our directors serve on boards of directors of our subsidiaries, for which service they are compensated in cash. The proposed amendment would include those fees in calculating the annual compensation limit. Director stock awards vest one year after the date of grant or, if earlier, at the date of the next annual meeting. However, awards that are scheduled to vest in less than 50 weeks after the date of grant will count against the 5% exception pool for the minimum vesting requirements described below. The awards vest earlier in case of death or a change in control. If a non-employee director retires before the one-year vesting date, a prorated amount of the award vests based on the number of days the non-employee director served during the vesting period before retirement. Awards may be deferred under the Bank of America Corporation Director Deferral Plan. See &#8220;Director compensation&#8221; on page 44 for additional details about our director compensation program. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Subject to the terms of the BACEP and any applicable award agreement, a participant may be entitled to receive dividends or dividend equivalents with respect to an award of restricted stock or RSUs. Dividends or dividend equivalents may be credited as cash or as additional shares or units. However, in no event will dividends or dividend equivalents vest or otherwise be paid out prior to the time that the underlying award (or portion thereof) has vested and, accordingly, any such dividends or dividend equivalents will be subject to cancellation and forfeiture if the underlying award does not vest (including both time-based and performance-based awards). </font></div><div style="margin-top:8pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Minimum vesting conditions </font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP provides that generally all stock-settled awards will vest no more quickly than ratably annually as of each anniversary over a three- year period beginning on the grant date of the award. This requirement does not apply to (i) certain substitute awards arising from acquisitions&#59; (ii) shares delivered in lieu of fully vested cash incentive awards&#59; (iii) awards to non-employee directors that vest on the earlier of the one-year anniversary of the date of grant or the next annual meeting of shareholders (but not sooner than 50 weeks after the grant date)&#59; or (iv) awards that vest based on the achievement of performance goals over a period of at least one year. Also, the Committee may grant equity-based awards without regard to the minimum vesting requirement with respect to a maximum of 5% of the available share reserve authorized for issuance under the BACEP. In addition, the minimum vesting requirement does not apply to the Committee&#8217;s discretion to provide for accelerated exercisability or vesting of any award, including in cases of retirement, workforce reduction, death, disability, or a change in control, in the terms of the award or otherwise. </font></div><div style="margin-top:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-top:8pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Section 162(m) award limits </font></div><div style="margin-top:3pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Prior to 2018, awards under the BACEP could be designed to qualify as &#8220;performance-based compensation&#8221; that were intended to be exempt from the deduction limits under Section 162(m) of the Code. Under the pre-2018 Section 162(m) rules, the plan under which awards were granted had to include certain shareholder-approved individual award limits in order for awards to qualify as performance-based compensation. The BACEP included such individual award limits, which were limited to options&#47;SARs and performance-based restricted stock and RSU awards that were intended to qualify for the Section 162(m) performance-based compensation exception. Although changes in the U.S. tax laws made by the Tax Cuts and Jobs Act of 2017 eliminated the &#8220;performance-based compensation&#8221; exception for grants made from and after January 1, 2018, the BACEP continues to include award limits, by which a participant may not be granted in any calendar year&#58; (i) stock options or SARs for more than 4,000,000 shares, or (ii) performance-based restricted stock shares&#47;RSUs for more than 4,000,000 shares (assuming maximum performance). </font></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Withholding for payment of taxes </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP provides for the withholding and payment by a participant of any payroll or withholding taxes required by applicable law. The BACEP permits a participant to satisfy this requirement, with the approval of the Committee and subject to the terms of the BACEP, by withholding from the participant a number of shares of the company&#8217;s common stock otherwise issuable under the award having a fair market value equal to the amount of applicable payroll and withholding taxes. It also permits the company and the participant to withhold at rates up to the maximum statutory tax rates. </font></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Adjustments for changes in capitalization </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">In the event of any change in the number of our outstanding shares of common stock by reason of any stock dividend, split, spin-off, recapitalization, merger, consolidation, combination, exchange of shares or otherwise, the aggregate number of shares of our common stock with respect to which awards may be made under the BACEP, the annual limit on individual awards, the limits on incentive stock options, restricted stock and RSUs, and the terms, types of shares and number of shares of any outstanding awards under the BACEP will be equitably adjusted by the Committee in its discretion to preserve the benefit of the award for us and the participant. </font></div><div style="margin-top:10pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">No single trigger vesting upon a change in control for employees </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP permits the Committee to provide for vesting of awards to employees in connection with a change in control of Bank of America if there is also a termination of employment in connection with the change in control. This is often referred to as &#8220;double trigger&#8221; vesting. For these purposes, a termination is considered to be in connection with a change in control if it occurs upon or within two years after the change in control and is for one of the following two reasons&#58; (i) an involuntary termination by the company without &#8220;cause&#8221; or (ii) a termination by the employee for &#8220;good reason.&#8221; &#8220;Cause&#8221; and &#8220;good reason&#8221; will be as defined in the applicable award agreements. In addition, the Committee may provide for the assumption or substitution of awards by a surviving corporation. Awards to non-employee directors fully vest upon a change in control. </font></div><div style="margin-top:10pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Amendment and termination of the Plan </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Our Board has the power to amend, modify, or terminate the BACEP on a prospective basis, provided that no termination, amendment, or modification shall adversely affect in any material way any award previously granted under the Plan without the written consent of any affected participant. Shareholder approval will be obtained for any change to the material terms of the BACEP to the extent required by NYSE listing requirements or other applicable law. The BACEP, as amended, automatically terminates at the close of business on April 21, 2035, following which no awards may be made under the BACEP. </font></div><div style="margin-top:10pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Option and SARs repricing prohibited </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The BACEP specifically prohibits the repricing of stock options or SARs without shareholder approval. For this purpose, a &#8220;repricing&#8221; means any of the following (or any other action that has the same effect as any of the following)&#58; (i) changing the terms of a stock option or SAR to lower its exercise price&#59; (ii) any other action that is treated as a &#8220;repricing&#8221; under generally accepted accounting principles&#59; and (iii) repurchasing for cash or canceling a stock option or SAR at a time when its exercise price is greater than the fair market value of the underlying stock in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">exchange for another award, unless the cancellation and exchange occurs in connection with change in capitalization or similar change. Such cancellation and exchange would be considered a &#8220;repricing&#8221; regardless of whether it is treated as a &#8220;repricing&#8221; under generally accepted accounting principles and regardless of whether it is voluntary on the part of the employee. </font></div><div style="margin-top:18pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Federal income tax treatment </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The following discussion summarizes certain U.S. federal income tax consequences of awards under the BACEP based on the law as in effect on the date of this document. The following discussion does not purport to cover federal employment taxes or other federal tax consequences that may be employed with awards, nor does it cover state, local, or non-U.S. taxes. </font></div><div style="margin-top:5pt"><font style="color:#cf0a2c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Nonqualified stock options.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> A participant generally will not recognize taxable income upon the grant or vesting of a nonqualified stock option with an exercise price at least equal to the fair market value of our common stock on the date of grant and no additional deferral feature. Upon the exercise of a nonqualified stock option, a participant generally will recognize compensation taxable as ordinary income in an amount equal to the difference between the fair market value of the shares underlying the stock option on the date of exercise and the exercise price of the stock option. When a participant sells the shares, the participant will have short-term or long-term capital gain or loss, as the case may be, equal to the difference between the amount the participant received from the sale and the tax basis of the shares sold. The tax basis of the shares generally will be equal to the fair market value of the shares on the exercise date.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#cf0a2c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Incentive stock options.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> A participant generally will not recognize taxable income upon the grant of an incentive stock option. If a participant exercises an incentive stock option during employment or within three months after employment ends (12 months in the case of permanent and total disability), the participant will not recognize taxable income at the time of exercise for regular U.S. federal income tax purposes (although the participant generally will have taxable income for alternative minimum tax purposes at that time as if the stock option were a nonqualified stock option). If a participant sells or otherwise disposes of the shares acquired upon exercise of an incentive stock option after the later of (a) one year from the date the participant exercised the option and (b) two years from the grant date of the stock option, the participant generally will recognize long-term capital gain or loss equal to the difference between the amount the participant received in the disposition and the exercise price of the stock option. If a participant sells or otherwise disposes of shares acquired upon exercise of an incentive stock option before these holding period requirements are satisfied, the disposition will constitute a &#8220;disqualifying disposition,&#8221; and the participant generally will recognize taxable ordinary income in the year of disposition equal to the excess of the fair market value of the shares on the date of exercise over the exercise price of the stock option (or, if less, the excess of the amount realized on the disposition of the shares over the exercise price of the stock option). The balance of the participant&#8217;s gain on a disqualifying disposition, if any, will be taxed as short-term or long-term capital gain, as the case may be. </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">With respect to both nonqualified stock options and incentive stock options, special rules apply if a participant uses shares of common stock already held by the participant to pay the exercise price or if the shares received upon exercise of the stock option are subject to a substantial risk of forfeiture by the participant. </font></div><div style="margin-top:5pt"><font style="color:#cf0a2c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Stock appreciation rights.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> A participant generally will not recognize taxable income upon the grant or vesting of a SAR with a grant price at least equal to the fair market value of our common stock on the date of grant and no additional deferral feature. Upon the exercise of a SAR, a participant generally will recognize compensation taxable as ordinary income in an amount equal to the difference between the fair market value of the shares underlying the SAR on the date of exercise and the grant price of the SAR. </font></div><div style="margin-top:5pt"><font style="color:#cf0a2c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Restricted stock shares and RSUs.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> A participant generally will not have taxable income upon the grant of restricted stock or RSUs. Instead, the participant will recognize ordinary income at the time of vesting or payout equal to the fair market value (on the vesting or payout date) of the shares or cash received minus any amount paid. For restricted stock only, a participant may instead elect to be taxed at the time of grant. </font></div><div style="margin-top:5pt"><font style="color:#cf0a2c;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Tax consequences to Bank of America.</font><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> In the foregoing cases, we generally will be entitled to a deduction at the same time, and in the same amount, as a participant recognizes ordinary income, subject to certain limitations imposed under the Code, including those imposed by Section 162(m) as applicable. </font></div><div style="margin-top:10pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">New stock plan benefits </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Because awards under the BACEP are discretionary, awards are generally not determinable at this time. For information regarding awards granted under the BACEP during the most recently completed fiscal year, see &#8220;Grants </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:700;line-height:120%"> </font></div></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">of plan-based awards table&#8221; on page 68 and &#8220;Director compensation&#8221; on page 44. As stated previously, in the event the proposed amendment and restatement is not approved by shareholders at the annual meeting, there are enough shares remaining under the Plan for the Board to grant restricted stock awards to directors elected at the annual meeting as part of 2025-2026 director compensation. </font></div><div style="margin-top:10pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Additional information </font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The table below presents information on equity compensation plans at December 31, 2024, as required by SEC disclosure rules. </font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:39.284%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.650%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:17.970%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:20.696%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-2.63pt;text-indent:4pt"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Plan Category</font><font style="color:#022169;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.31pt;text-align:center"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(a)<br>Number of Shares to<br>be Issued Under<br>Outstanding Options,<br>Warrants and<br>Rights</font><font style="color:#022169;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.31pt;text-align:center"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(b)<br>Weighted-Average<br>Exercise Price of<br>Outstanding Options,<br>Warrants and<br>Rights</font><font style="color:#022169;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-right:-1.31pt;text-align:center"><font style="color:#022169;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(c)<br>Number of Shares<br>Remaining for Future<br>Issuance Under Equity<br>Compensation Plans<br>(Excluding Securities<br>Reflected in Column (a))</font><font style="color:#022169;font-family:'Arial',sans-serif;font-size:3.9pt;font-weight:700;line-height:120%;position:relative;top:-2.1pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="display:none"></td></tr><tr style="height:5pt"><td colspan="3" style="border-top:1pt solid #022169;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #022169;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #022169;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #022169;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plans approved by shareholders</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269,213,186</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,387,893</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Plans not approved by shareholders</font></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="display:none"></td></tr><tr style="height:4pt"><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:0.75pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #022169;padding:2px 1pt 2px 2.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Total</font></td><td colspan="3" style="border-bottom:1pt solid #022169;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">269,213,186</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:0.75pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">-</font></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #022169;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">158,387,893</font></td><td colspan="3" style="display:none"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:5pt;font-weight:400;line-height:120%">&#160;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:1.883%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.817%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(1)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:120%">This table does not include 421,369 vested RSUs and stock option gain deferrals at December 31, 2024 that were assumed by the Corporation in connection with prior acquisitions under whose plans the awards were originally granted. </font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(2)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Consists of outstanding RSUs. Includes 4,225,165 vested RSUs subject to a required post-vest holding period.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(3)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Restricted stock units do not have an exercise price and are delivered without any payment or consideration.</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:2pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:4.55pt;font-weight:400;line-height:100%;position:relative;top:-2.44pt;vertical-align:baseline">(4)</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:400;line-height:100%">Amount represents shares of common stock available for future issuance under the BACEP.</font></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:2pt;font-weight:400;line-height:120%">&#160;</font></div><div><font><br></font></div><div style="margin-top:5pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">No options or SARs have been granted to any current NEO, current executive officer, or any associate of such person, nor to any other employee or person since shareholders approved the last amendment to the BACEP in 2024.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;</font></div><div><font style="color:#ffffff;font-family:'Arial',sans-serif;font-size:0.5pt;font-weight:400;line-height:120%">THIS IS A VOTING INSTRUCTION FORM. VOTING INSTRUCTIONS You are receiving this voting instruction form because you hold shares in the above Security. You have the right to vote on proposals being presented at the upcoming Annual Meeting to be held on VOTING INSTRUCTIONS V65929-P26502 THIS VOTING INSTRUCTION FORM IS VALID ONLY WHEN SIGNED AND DATED. PLEASE USE BLUE OR BLACK INK AND RETURN ONLY THE BOTTOM PORTION. The Board recommends you vote FOR the following proposal(s)&#58; 1 through 4 For Against Abstain 1. Electing Directors Nominees&#58; 1a. Sharon L. Allen 1b. Jos&#233; (Joe) E. Almeida 1c. Pierre J.P. de Weck 1d. Arnold W. Donald 1e. Linda P. Hudson 1f. Monica C. Lozano 1g. Maria N. Martinez 1h. Brian T. Moynihan 1i. Lionel L. Nowell III 1j. Denise L. Ramos 1k. Clayton S. Rose 1l. Michael D. White 1m. Thomas D. Woods 1n. Maria T. Zuber For Against Abstain 2. Approving our executive compensation (an advisory, non-binding &#8220;Say on Pay&#8221; resolution) 3. Ratifying the appointment of our independent registered public accounting firm for 2025 4. Amending and restating the Bank of America Corporation Equity Plan The Board recommends you vote AGAINST the following proposal(s)&#58; 5 through 8 For Against Abstain 5. Shareholder proposal requesting the nomination of more director candidates than board seats 6. Shareholder proposal requesting report on board oversight of risks related to animal welfare 7. Shareholder proposal requesting report on lobbying alignment with Bank of America&#8217;s climate goals 8. Shareholder proposal requesting disclosure of energy financing ratio For Against Abstain NOTE&#58; Such other business as may properly come before the meeting or any adjournment thereof. Signature &#91;PLEASE SIGN WITHIN BOX&#93; Date </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>bac-20250422.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2cc093cd-33e9-4e28-9f1d-e9dcb35803c7,g:07d1049a-4b93-4e26-bdd7-e13d1ffcf13e-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:bac="http://www.bankofamerica.com/20250422" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.bankofamerica.com/20250422">
  <xs:import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bac-20250422_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bac-20250422_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="bac-20250422_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.bankofamerica.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="bac_SeriesGGPreferredStockMember" abstract="true" name="SeriesGGPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeriesHHPreferredStockMember" abstract="true" name="SeriesHHPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeriesLPreferredStockMember" abstract="true" name="SeriesLPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_Series1PreferredStockMember" abstract="true" name="Series1PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_Series2PreferredStockMember" abstract="true" name="Series2PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_Series4PreferredStockMember" abstract="true" name="Series4PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_Series5PreferredStockMember" abstract="true" name="Series5PreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember" abstract="true" name="FloatingRatePreferredHybridIncomeTermSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" abstract="true" name="A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_IncomeCapitalObligationNotesMember" abstract="true" name="IncomeCapitalObligationNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" abstract="true" name="SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeriesKKPreferredStockMember" abstract="true" name="SeriesKKPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeriesLLPreferredStockMember" abstract="true" name="SeriesLLPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeriesNNPreferredStockMember" abstract="true" name="SeriesNNPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeriesPPPreferredStockMember" abstract="true" name="SeriesPPPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_SeriesQQPreferredStockMember" abstract="true" name="SeriesQQPreferredStockMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" abstract="true" name="DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>5
<FILENAME>bac-20250422_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2cc093cd-33e9-4e28-9f1d-e9dcb35803c7,g:07d1049a-4b93-4e26-bdd7-e13d1ffcf13e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.bankofamerica.com/role/CoverPage" xlink:type="simple" xlink:href="bac-20250422.xsd#CoverPage"/>
  <link:definitionLink xlink:role="http://www.bankofamerica.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_6b93c3f3-c38c-45d2-ae16-89fb41f168aa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_DocumentInformationTable_6b93c3f3-c38c-45d2-ae16-89fb41f168aa" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3f8d8694-4f6f-4caf-8238-74f56b994374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_6b93c3f3-c38c-45d2-ae16-89fb41f168aa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3f8d8694-4f6f-4caf-8238-74f56b994374" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_3f8d8694-4f6f-4caf-8238-74f56b994374_default" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3f8d8694-4f6f-4caf-8238-74f56b994374" xlink:to="loc_us-gaap_ClassOfStockDomain_3f8d8694-4f6f-4caf-8238-74f56b994374_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3f8d8694-4f6f-4caf-8238-74f56b994374" xlink:to="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_63da3ae9-8f2b-420b-a1ee-e0786b4ce8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_us-gaap_CommonStockMember_63da3ae9-8f2b-420b-a1ee-e0786b4ce8e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_daf3228f-eec2-4493-897c-3e27e2a1b704" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_daf3228f-eec2-4493-897c-3e27e2a1b704" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesGGPreferredStockMember_472ddd34-659e-451b-b296-293246a7f83a" xlink:href="bac-20250422.xsd#bac_SeriesGGPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesGGPreferredStockMember_472ddd34-659e-451b-b296-293246a7f83a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesHHPreferredStockMember_844278fb-410f-476b-a495-0365e2f6b29b" xlink:href="bac-20250422.xsd#bac_SeriesHHPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesHHPreferredStockMember_844278fb-410f-476b-a495-0365e2f6b29b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesLPreferredStockMember_ce5f181c-658d-490c-9dd9-f1e468c7163f" xlink:href="bac-20250422.xsd#bac_SeriesLPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesLPreferredStockMember_ce5f181c-658d-490c-9dd9-f1e468c7163f" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series1PreferredStockMember_f9006d36-eda0-4100-bed6-fd4de8929d5f" xlink:href="bac-20250422.xsd#bac_Series1PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series1PreferredStockMember_f9006d36-eda0-4100-bed6-fd4de8929d5f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series2PreferredStockMember_26970a37-f0fd-4be7-b47a-759115b8b9aa" xlink:href="bac-20250422.xsd#bac_Series2PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series2PreferredStockMember_26970a37-f0fd-4be7-b47a-759115b8b9aa" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series4PreferredStockMember_08e03b90-6916-4c72-a61f-90489b73facc" xlink:href="bac-20250422.xsd#bac_Series4PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series4PreferredStockMember_08e03b90-6916-4c72-a61f-90489b73facc" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series5PreferredStockMember_e0d0681e-0b00-4fc8-8849-b416f6565a9e" xlink:href="bac-20250422.xsd#bac_Series5PreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series5PreferredStockMember_e0d0681e-0b00-4fc8-8849-b416f6565a9e" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember_3f6c1cea-125e-41b7-89e0-e352217baed7" xlink:href="bac-20250422.xsd#bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember_3f6c1cea-125e-41b7-89e0-e352217baed7" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember_8887217d-ad45-40db-99a8-bb81af010d91" xlink:href="bac-20250422.xsd#bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember_8887217d-ad45-40db-99a8-bb81af010d91" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_IncomeCapitalObligationNotesMember_2de60405-9047-4e85-8200-fd796e3a1e72" xlink:href="bac-20250422.xsd#bac_IncomeCapitalObligationNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_IncomeCapitalObligationNotesMember_2de60405-9047-4e85-8200-fd796e3a1e72" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember_754c36fa-a4b4-41db-a842-7dfae0296bef" xlink:href="bac-20250422.xsd#bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember_754c36fa-a4b4-41db-a842-7dfae0296bef" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesKKPreferredStockMember_707a2394-1f18-4b0a-a834-9b0104a628c6" xlink:href="bac-20250422.xsd#bac_SeriesKKPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesKKPreferredStockMember_707a2394-1f18-4b0a-a834-9b0104a628c6" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesLLPreferredStockMember_138762e9-abe7-43cc-bda0-8c5ceab6803c" xlink:href="bac-20250422.xsd#bac_SeriesLLPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesLLPreferredStockMember_138762e9-abe7-43cc-bda0-8c5ceab6803c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesNNPreferredStockMember_43c31439-573a-4e45-80bb-9e5d32faea3a" xlink:href="bac-20250422.xsd#bac_SeriesNNPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesNNPreferredStockMember_43c31439-573a-4e45-80bb-9e5d32faea3a" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesPPPreferredStockMember_f1414a21-a3bc-43a4-99f3-485a4c17424c" xlink:href="bac-20250422.xsd#bac_SeriesPPPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesPPPreferredStockMember_f1414a21-a3bc-43a4-99f3-485a4c17424c" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesQQPreferredStockMember_9203d91c-9456-408d-8601-135b9de7f087" xlink:href="bac-20250422.xsd#bac_SeriesQQPreferredStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesQQPreferredStockMember_9203d91c-9456-408d-8601-135b9de7f087" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember_ed0c70c3-2cf0-4735-a182-72c07acfc268" xlink:href="bac-20250422.xsd#bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember_ed0c70c3-2cf0-4735-a182-72c07acfc268" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4d573083-13de-4784-b427-044bdcc79b96" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_DocumentType_4d573083-13de-4784-b427-044bdcc79b96" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8c7d5ba6-7e73-4816-b38e-e73367654592" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_DocumentPeriodEndDate_8c7d5ba6-7e73-4816-b38e-e73367654592" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5dd0f7a6-79c9-4ab5-8a9d-876f481d6adf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityRegistrantName_5dd0f7a6-79c9-4ab5-8a9d-876f481d6adf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_79966a06-faf3-42ae-901e-280da4cc1a4d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityIncorporationStateCountryCode_79966a06-faf3-42ae-901e-280da4cc1a4d" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f2784e3-735c-444b-8a4e-86d640a27739" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityFileNumber_2f2784e3-735c-444b-8a4e-86d640a27739" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2f23f2de-980e-435a-b6a7-0bb8293681fd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityTaxIdentificationNumber_2f23f2de-980e-435a-b6a7-0bb8293681fd" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dab409dc-db10-43c7-a41e-d8437b99ccaf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressAddressLine1_dab409dc-db10-43c7-a41e-d8437b99ccaf" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a86857bb-9b52-43bf-8709-a60f96a126df" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressCityOrTown_a86857bb-9b52-43bf-8709-a60f96a126df" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e83d1388-1e69-4d4c-aa76-aa5d88508f8f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressStateOrProvince_e83d1388-1e69-4d4c-aa76-aa5d88508f8f" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a2e2cc96-db1a-4157-b3cd-7737226310c8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressPostalZipCode_a2e2cc96-db1a-4157-b3cd-7737226310c8" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dfc1e3e0-5a37-40bc-8890-8bd616075f52" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_CityAreaCode_dfc1e3e0-5a37-40bc-8890-8bd616075f52" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7809993e-0247-4f52-9c54-b571644cb08e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_LocalPhoneNumber_7809993e-0247-4f52-9c54-b571644cb08e" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_b8712a7d-a4ca-456a-a93d-f6e4f28c7d1e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_WrittenCommunications_b8712a7d-a4ca-456a-a93d-f6e4f28c7d1e" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_80ff23c0-ff28-43a1-914e-9b9a34801078" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_SolicitingMaterial_80ff23c0-ff28-43a1-914e-9b9a34801078" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6ed66f27-e0d6-4d52-8d00-7ea3d82cf107" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_PreCommencementTenderOffer_6ed66f27-e0d6-4d52-8d00-7ea3d82cf107" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_a03dfdff-0e31-46d2-a7ab-e88c5dd76001" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_a03dfdff-0e31-46d2-a7ab-e88c5dd76001" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_21d63e69-0dd5-4d09-85ba-d25aa8767445" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_Security12bTitle_21d63e69-0dd5-4d09-85ba-d25aa8767445" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_839bfea9-d5b5-479c-9a5c-a2bbc0bf0832" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_TradingSymbol_839bfea9-d5b5-479c-9a5c-a2bbc0bf0832" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_00dce7d4-1eb1-4a0c-921d-dd5d658104af" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_SecurityExchangeName_00dce7d4-1eb1-4a0c-921d-dd5d658104af" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_72787f3a-dd38-4e4f-86d0-b119160a6bed" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityEmergingGrowthCompany_72787f3a-dd38-4e4f-86d0-b119160a6bed" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5cdd1164-b59c-493c-a4b6-d31b10953fb3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityCentralIndexKey_5cdd1164-b59c-493c-a4b6-d31b10953fb3" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4f5ecb2b-5f31-43a1-807b-79ea39d713fa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_AmendmentFlag_4f5ecb2b-5f31-43a1-807b-79ea39d713fa" xlink:type="arc" order="21"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>6
<FILENAME>bac-20250422_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2cc093cd-33e9-4e28-9f1d-e9dcb35803c7,g:07d1049a-4b93-4e26-bdd7-e13d1ffcf13e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ClassOfStockDomain_469ad3d9-fe3f-471a-b117-226049f84147_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesKKPreferredStockMember_334f914b-7572-4053-b140-55c97239806f_terseLabel_en-US" xlink:label="lab_bac_SeriesKKPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series KK</link:label>
    <link:label id="lab_bac_SeriesKKPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesKKPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series KK Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesKKPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesKKPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series KK Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesKKPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesKKPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesKKPreferredStockMember" xlink:to="lab_bac_SeriesKKPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_d49e2146-de2e-4643-a571-8a701bb7bb97_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesLLPreferredStockMember_3ba32005-87c5-4834-aded-0649b35f3a35_terseLabel_en-US" xlink:label="lab_bac_SeriesLLPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 5.000% Non-Cumulative Preferred Stock, Series LL</link:label>
    <link:label id="lab_bac_SeriesLLPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesLLPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series LL Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesLLPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesLLPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series LL Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesLLPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesLLPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesLLPreferredStockMember" xlink:to="lab_bac_SeriesLLPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_Series1PreferredStockMember_a0fadb95-3e0b-4238-b621-6c03be18c551_verboseLabel_en-US" xlink:label="lab_bac_Series1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 1</link:label>
    <link:label id="lab_bac_Series1PreferredStockMember_label_en-US" xlink:label="lab_bac_Series1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series 1 Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_Series1PreferredStockMember_documentation_en-US" xlink:label="lab_bac_Series1PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series 1 Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series1PreferredStockMember" xlink:href="bac-20250422.xsd#bac_Series1PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_Series1PreferredStockMember" xlink:to="lab_bac_Series1PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesGGPreferredStockMember_7c9bd727-3f69-43eb-85ee-81f3b703b1dd_verboseLabel_en-US" xlink:label="lab_bac_SeriesGGPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 6.000% Non-Cumulative Preferred Stock, Series GG</link:label>
    <link:label id="lab_bac_SeriesGGPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesGGPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series GG Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesGGPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesGGPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series GG Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesGGPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesGGPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesGGPreferredStockMember" xlink:to="lab_bac_SeriesGGPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesHHPreferredStockMember_b8463e80-ad26-4f9a-b396-ad20efc19ec3_verboseLabel_en-US" xlink:label="lab_bac_SeriesHHPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 5.875% Non-Cumulative Preferred Stock, HH</link:label>
    <link:label id="lab_bac_SeriesHHPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesHHPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series HH Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesHHPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesHHPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series HH Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesHHPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesHHPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesHHPreferredStockMember" xlink:to="lab_bac_SeriesHHPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_60ca0526-e2cf-4de2-a89a-32f31f9060c5_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_7b6686ca-e0f8-41c6-ae2b-331494e6ee4d_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_bd46bc00-f668-4efa-aa7b-f76b564e0c5d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember_bf8dbe2a-31de-4c1b-883f-73f1ff001a44_terseLabel_en-US" xlink:label="lab_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIII (and the guarantee related thereto)</link:label>
    <link:label id="lab_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember_label_en-US" xlink:label="lab_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Floating Rate Preferred Hybrid Income Term Securities [Member]</link:label>
    <link:label id="lab_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember_documentation_en-US" xlink:label="lab_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Floating Rate Preferred Hybrid Income Term Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:href="bac-20250422.xsd#bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:to="lab_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_c81e709b-4ad5-42c3-a260-660e4e60269e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_271823d4-16bc-4461-9c1d-9d9d5d38bd53_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_806b6b1e-8f68-426a-bc3f-aa9faa99d293_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_e484e8be-4842-4917-b9c3-af9978b73f7b_verboseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Common Stock, par value $0.01 per share</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_Series4PreferredStockMember_3910e387-6099-4707-a49f-11f8cd1ecefa_verboseLabel_en-US" xlink:label="lab_bac_Series4PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 4</link:label>
    <link:label id="lab_bac_Series4PreferredStockMember_label_en-US" xlink:label="lab_bac_Series4PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series 4 Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_Series4PreferredStockMember_documentation_en-US" xlink:label="lab_bac_Series4PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series Four Preferred Stock member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series4PreferredStockMember" xlink:href="bac-20250422.xsd#bac_Series4PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_Series4PreferredStockMember" xlink:to="lab_bac_Series4PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_6112cf24-706c-4ba5-a6cc-a216b5244f00_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_18191ae9-5476-424d-94ea-af3db0522cd5_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesLPreferredStockMember_4af7b2cf-ede4-4010-8d78-0ebc169e0efe_netLabel_en-US" xlink:label="lab_bac_SeriesLPreferredStockMember" xlink:role="http://www.xbrl.org/2009/role/netLabel" xlink:type="resource" xml:lang="en-US">7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L</link:label>
    <link:label id="lab_bac_SeriesLPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesLPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series L Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesLPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesLPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series L Preferred Stock Member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesLPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesLPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesLPreferredStockMember" xlink:to="lab_bac_SeriesLPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_13411161-e2b7-414b-845a-d1b8c8f54332_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_454833fc-e6fb-4f18-aafe-2b341c67d646_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_ac9ec96d-63bd-4ce0-8266-9dac9a016dea_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember_fecbbb27-793f-4982-8b8b-97d3385d9877_terseLabel_en-US" xlink:label="lab_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIV (and the guarantee related thereto)</link:label>
    <link:label id="lab_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember_label_en-US" xlink:label="lab_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities [Member]</link:label>
    <link:label id="lab_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember_documentation_en-US" xlink:label="lab_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:href="bac-20250422.xsd#bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:to="lab_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_4c0d030f-9fbd-4e55-a4a0-545bce01dfa7_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_IncomeCapitalObligationNotesMember_4666db7c-f2a7-4b18-a04d-5a4855a0bdad_terseLabel_en-US" xlink:label="lab_bac_IncomeCapitalObligationNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Income Capital Obligation Notes initially due December 15, 2066 of Bank of America Corporation</link:label>
    <link:label id="lab_bac_IncomeCapitalObligationNotesMember_label_en-US" xlink:label="lab_bac_IncomeCapitalObligationNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Income Capital Obligation Notes [Member]</link:label>
    <link:label id="lab_bac_IncomeCapitalObligationNotesMember_documentation_en-US" xlink:label="lab_bac_IncomeCapitalObligationNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Income Capital Obligation Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_IncomeCapitalObligationNotesMember" xlink:href="bac-20250422.xsd#bac_IncomeCapitalObligationNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_IncomeCapitalObligationNotesMember" xlink:to="lab_bac_IncomeCapitalObligationNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_Series5PreferredStockMember_08dd69ca-ecb8-44a7-ad16-1d42feb29e96_verboseLabel_en-US" xlink:label="lab_bac_Series5PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 5</link:label>
    <link:label id="lab_bac_Series5PreferredStockMember_label_en-US" xlink:label="lab_bac_Series5PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series 5 Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_Series5PreferredStockMember_documentation_en-US" xlink:label="lab_bac_Series5PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series Five Preferred Stock member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series5PreferredStockMember" xlink:href="bac-20250422.xsd#bac_Series5PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_Series5PreferredStockMember" xlink:to="lab_bac_Series5PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_b0b8f41c-1c8b-4589-beef-5f35cffa8e02_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_Series2PreferredStockMember_cb723fe0-b3a9-4052-a825-f634c170a049_verboseLabel_en-US" xlink:label="lab_bac_Series2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 2</link:label>
    <link:label id="lab_bac_Series2PreferredStockMember_label_en-US" xlink:label="lab_bac_Series2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series 2 Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_Series2PreferredStockMember_documentation_en-US" xlink:label="lab_bac_Series2PreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series Two Preferred Stock member.</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series2PreferredStockMember" xlink:href="bac-20250422.xsd#bac_Series2PreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_Series2PreferredStockMember" xlink:to="lab_bac_Series2PreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_47951ff7-aa32-47e9-b8e3-a7dda84c89ad_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_bb040115-26d1-4464-8211-7057c8f10a76_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_61be6211-1f3f-4862-aa47-1463f6b6f72f_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_ef0659e0-adf4-43d1-8eab-1f1762f7e3e3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_1691535a-e6b2-4815-8e8e-bde59b9e4876_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_807bf327-6ef2-4199-abb4-1efd7d519608_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_deb8ee68-07a2-488d-aade-bde2e785a023_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_0f0543bf-b347-4cf2-a5b0-87e4c6f7f0f8_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_72136dd2-8b37-4785-bc90-afb50585063f_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b206e8c0-803c-48bb-a08c-5d10d399d31d_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_86f107aa-6310-410f-bd33-c324fcccae89_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember_b9116f0b-8ee5-4cfc-88d6-f42185ac30a7_terseLabel_en-US" xlink:label="lab_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS</link:label>
    <link:label id="lab_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember_label_en-US" xlink:label="lab_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS [Member]</link:label>
    <link:label id="lab_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember_documentation_en-US" xlink:label="lab_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" xlink:href="bac-20250422.xsd#bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" xlink:to="lab_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesPPPreferredStockMember_ebceb7cf-884d-4094-adad-475698096218_terseLabel_en-US" xlink:label="lab_bac_SeriesPPPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 4.125% Non-Cumulative Preferred Stock, Series PP</link:label>
    <link:label id="lab_bac_SeriesPPPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesPPPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series PP Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesPPPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesPPPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series PP Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesPPPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesPPPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesPPPreferredStockMember" xlink:to="lab_bac_SeriesPPPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesQQPreferredStockMember_9d29fd94-5013-47dd-8d7d-0fe86f93bd3a_terseLabel_en-US" xlink:label="lab_bac_SeriesQQPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 4.250% Non-Cumulative Preferred Stock, Series QQ</link:label>
    <link:label id="lab_bac_SeriesQQPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesQQPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series QQ Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesQQPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesQQPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series QQ Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesQQPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesQQPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesQQPreferredStockMember" xlink:to="lab_bac_SeriesQQPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_088b4951-ac0d-47d8-8c78-136b48754365_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember_375e3a27-906e-458a-be90-dc9583e8cd21_terseLabel_en-US" xlink:label="lab_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Senior Medium-Term Notes, Series A, Step Up Callable Notes, due November 28, 2031 of BofA Finance LLC (and the guarantee of the Registrant with respect thereto)</link:label>
    <link:label id="lab_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember_label_en-US" xlink:label="lab_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Senior Medium-Term Notes, Series A, Step Up Callable Notes [Member]</link:label>
    <link:label id="lab_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember_documentation_en-US" xlink:label="lab_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Senior Medium-Term Notes, Series A, Step Up Callable Notes [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" xlink:href="bac-20250422.xsd#bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" xlink:to="lab_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_bac_SeriesNNPreferredStockMember_d0749d36-38a2-4a0b-97ad-723b57d18b3e_terseLabel_en-US" xlink:label="lab_bac_SeriesNNPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of 4.375% Non-Cumulative Preferred Stock, Series NN</link:label>
    <link:label id="lab_bac_SeriesNNPreferredStockMember_label_en-US" xlink:label="lab_bac_SeriesNNPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series NN Preferred Stock [Member]</link:label>
    <link:label id="lab_bac_SeriesNNPreferredStockMember_documentation_en-US" xlink:label="lab_bac_SeriesNNPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xml:lang="en-US">Series NN Preferred Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesNNPreferredStockMember" xlink:href="bac-20250422.xsd#bac_SeriesNNPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_bac_SeriesNNPreferredStockMember" xlink:to="lab_bac_SeriesNNPreferredStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_1c0a3544-1582-41ad-846e-8e5443a48b19_verboseLabel_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xml:lang="en-US">Depositary Shares, each representing a 1/1,000th interest in a share of Floating Rate Non-Cumulative Preferred Stock, Series E</link:label>
    <link:label id="lab_us-gaap_SeriesEPreferredStockMember_label_en-US" xlink:label="lab_us-gaap_SeriesEPreferredStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Series E Preferred Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SeriesEPreferredStockMember" xlink:to="lab_us-gaap_SeriesEPreferredStockMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>7
<FILENAME>bac-20250422_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:2cc093cd-33e9-4e28-9f1d-e9dcb35803c7,g:07d1049a-4b93-4e26-bdd7-e13d1ffcf13e-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.bankofamerica.com/role/CoverPage" xlink:type="simple" xlink:href="bac-20250422.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.bankofamerica.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_56275144-5863-4452-ad4f-0508565d87bd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_6b93c3f3-c38c-45d2-ae16-89fb41f168aa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_56275144-5863-4452-ad4f-0508565d87bd" xlink:to="loc_dei_DocumentInformationTable_6b93c3f3-c38c-45d2-ae16-89fb41f168aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_3f8d8694-4f6f-4caf-8238-74f56b994374" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_6b93c3f3-c38c-45d2-ae16-89fb41f168aa" xlink:to="loc_us-gaap_StatementClassOfStockAxis_3f8d8694-4f6f-4caf-8238-74f56b994374" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_3f8d8694-4f6f-4caf-8238-74f56b994374" xlink:to="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_63da3ae9-8f2b-420b-a1ee-e0786b4ce8e5" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_us-gaap_CommonStockMember_63da3ae9-8f2b-420b-a1ee-e0786b4ce8e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SeriesEPreferredStockMember_daf3228f-eec2-4493-897c-3e27e2a1b704" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_SeriesEPreferredStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_us-gaap_SeriesEPreferredStockMember_daf3228f-eec2-4493-897c-3e27e2a1b704" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesGGPreferredStockMember_472ddd34-659e-451b-b296-293246a7f83a" xlink:href="bac-20250422.xsd#bac_SeriesGGPreferredStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesGGPreferredStockMember_472ddd34-659e-451b-b296-293246a7f83a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesHHPreferredStockMember_844278fb-410f-476b-a495-0365e2f6b29b" xlink:href="bac-20250422.xsd#bac_SeriesHHPreferredStockMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesHHPreferredStockMember_844278fb-410f-476b-a495-0365e2f6b29b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesLPreferredStockMember_ce5f181c-658d-490c-9dd9-f1e468c7163f" xlink:href="bac-20250422.xsd#bac_SeriesLPreferredStockMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesLPreferredStockMember_ce5f181c-658d-490c-9dd9-f1e468c7163f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/netLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series1PreferredStockMember_f9006d36-eda0-4100-bed6-fd4de8929d5f" xlink:href="bac-20250422.xsd#bac_Series1PreferredStockMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series1PreferredStockMember_f9006d36-eda0-4100-bed6-fd4de8929d5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series2PreferredStockMember_26970a37-f0fd-4be7-b47a-759115b8b9aa" xlink:href="bac-20250422.xsd#bac_Series2PreferredStockMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series2PreferredStockMember_26970a37-f0fd-4be7-b47a-759115b8b9aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series4PreferredStockMember_08e03b90-6916-4c72-a61f-90489b73facc" xlink:href="bac-20250422.xsd#bac_Series4PreferredStockMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series4PreferredStockMember_08e03b90-6916-4c72-a61f-90489b73facc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_Series5PreferredStockMember_e0d0681e-0b00-4fc8-8849-b416f6565a9e" xlink:href="bac-20250422.xsd#bac_Series5PreferredStockMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_Series5PreferredStockMember_e0d0681e-0b00-4fc8-8849-b416f6565a9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember_3f6c1cea-125e-41b7-89e0-e352217baed7" xlink:href="bac-20250422.xsd#bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember_3f6c1cea-125e-41b7-89e0-e352217baed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember_8887217d-ad45-40db-99a8-bb81af010d91" xlink:href="bac-20250422.xsd#bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember_8887217d-ad45-40db-99a8-bb81af010d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_IncomeCapitalObligationNotesMember_2de60405-9047-4e85-8200-fd796e3a1e72" xlink:href="bac-20250422.xsd#bac_IncomeCapitalObligationNotesMember"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_IncomeCapitalObligationNotesMember_2de60405-9047-4e85-8200-fd796e3a1e72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember_754c36fa-a4b4-41db-a842-7dfae0296bef" xlink:href="bac-20250422.xsd#bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember_754c36fa-a4b4-41db-a842-7dfae0296bef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesKKPreferredStockMember_707a2394-1f18-4b0a-a834-9b0104a628c6" xlink:href="bac-20250422.xsd#bac_SeriesKKPreferredStockMember"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesKKPreferredStockMember_707a2394-1f18-4b0a-a834-9b0104a628c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesLLPreferredStockMember_138762e9-abe7-43cc-bda0-8c5ceab6803c" xlink:href="bac-20250422.xsd#bac_SeriesLLPreferredStockMember"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesLLPreferredStockMember_138762e9-abe7-43cc-bda0-8c5ceab6803c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesNNPreferredStockMember_43c31439-573a-4e45-80bb-9e5d32faea3a" xlink:href="bac-20250422.xsd#bac_SeriesNNPreferredStockMember"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesNNPreferredStockMember_43c31439-573a-4e45-80bb-9e5d32faea3a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesPPPreferredStockMember_f1414a21-a3bc-43a4-99f3-485a4c17424c" xlink:href="bac-20250422.xsd#bac_SeriesPPPreferredStockMember"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesPPPreferredStockMember_f1414a21-a3bc-43a4-99f3-485a4c17424c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_SeriesQQPreferredStockMember_9203d91c-9456-408d-8601-135b9de7f087" xlink:href="bac-20250422.xsd#bac_SeriesQQPreferredStockMember"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_SeriesQQPreferredStockMember_9203d91c-9456-408d-8601-135b9de7f087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember_ed0c70c3-2cf0-4735-a182-72c07acfc268" xlink:href="bac-20250422.xsd#bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_57de66ea-0ee1-48f0-a30a-d47610dd668e" xlink:to="loc_bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember_ed0c70c3-2cf0-4735-a182-72c07acfc268" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_6b93c3f3-c38c-45d2-ae16-89fb41f168aa" xlink:to="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_4d573083-13de-4784-b427-044bdcc79b96" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_DocumentType_4d573083-13de-4784-b427-044bdcc79b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_8c7d5ba6-7e73-4816-b38e-e73367654592" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_DocumentPeriodEndDate_8c7d5ba6-7e73-4816-b38e-e73367654592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5dd0f7a6-79c9-4ab5-8a9d-876f481d6adf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityRegistrantName_5dd0f7a6-79c9-4ab5-8a9d-876f481d6adf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_79966a06-faf3-42ae-901e-280da4cc1a4d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityIncorporationStateCountryCode_79966a06-faf3-42ae-901e-280da4cc1a4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_2f2784e3-735c-444b-8a4e-86d640a27739" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityFileNumber_2f2784e3-735c-444b-8a4e-86d640a27739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_2f23f2de-980e-435a-b6a7-0bb8293681fd" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityTaxIdentificationNumber_2f23f2de-980e-435a-b6a7-0bb8293681fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dab409dc-db10-43c7-a41e-d8437b99ccaf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressAddressLine1_dab409dc-db10-43c7-a41e-d8437b99ccaf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_a86857bb-9b52-43bf-8709-a60f96a126df" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressCityOrTown_a86857bb-9b52-43bf-8709-a60f96a126df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_e83d1388-1e69-4d4c-aa76-aa5d88508f8f" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressStateOrProvince_e83d1388-1e69-4d4c-aa76-aa5d88508f8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a2e2cc96-db1a-4157-b3cd-7737226310c8" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityAddressPostalZipCode_a2e2cc96-db1a-4157-b3cd-7737226310c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_dfc1e3e0-5a37-40bc-8890-8bd616075f52" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_CityAreaCode_dfc1e3e0-5a37-40bc-8890-8bd616075f52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_7809993e-0247-4f52-9c54-b571644cb08e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_LocalPhoneNumber_7809993e-0247-4f52-9c54-b571644cb08e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_b8712a7d-a4ca-456a-a93d-f6e4f28c7d1e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_WrittenCommunications_b8712a7d-a4ca-456a-a93d-f6e4f28c7d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_80ff23c0-ff28-43a1-914e-9b9a34801078" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_SolicitingMaterial_80ff23c0-ff28-43a1-914e-9b9a34801078" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_6ed66f27-e0d6-4d52-8d00-7ea3d82cf107" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_PreCommencementTenderOffer_6ed66f27-e0d6-4d52-8d00-7ea3d82cf107" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_a03dfdff-0e31-46d2-a7ab-e88c5dd76001" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_a03dfdff-0e31-46d2-a7ab-e88c5dd76001" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_21d63e69-0dd5-4d09-85ba-d25aa8767445" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_Security12bTitle_21d63e69-0dd5-4d09-85ba-d25aa8767445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_839bfea9-d5b5-479c-9a5c-a2bbc0bf0832" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_TradingSymbol_839bfea9-d5b5-479c-9a5c-a2bbc0bf0832" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_00dce7d4-1eb1-4a0c-921d-dd5d658104af" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_SecurityExchangeName_00dce7d4-1eb1-4a0c-921d-dd5d658104af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_72787f3a-dd38-4e4f-86d0-b119160a6bed" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityEmergingGrowthCompany_72787f3a-dd38-4e4f-86d0-b119160a6bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_5cdd1164-b59c-493c-a4b6-d31b10953fb3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_EntityCentralIndexKey_5cdd1164-b59c-493c-a4b6-d31b10953fb3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_4f5ecb2b-5f31-43a1-807b-79ea39d713fa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_674fa96d-353d-41e9-bc87-963d79a79073" xlink:to="loc_dei_AmendmentFlag_4f5ecb2b-5f31-43a1-807b-79ea39d713fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Apr. 22, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 22,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">BANK OF AMERICA CORPORATION<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">1-6523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">56-0906609<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 North Tryon Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Charlotte<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">28255<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">704<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">386-5681<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000070858<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock, par value $0.01 per share</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, par value $0.01 per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of Floating Rate Non-Cumulative Preferred Stock, Series E</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share  of Floating Rate Non-Cumulative Preferred Stock, Series E<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesGGPreferredStockMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of 6.000% Non-Cumulative Preferred Stock, Series GG</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 6.000% Non-Cumulative Preferred Stock, Series GG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrB<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesHHPreferredStockMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of 5.875% Non-Cumulative Preferred Stock, HH</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 5.875% Non-Cumulative Preferred Stock, Series HH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesLPreferredStockMember', window );">7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_Series1PreferredStockMember', window );">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 1</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,200th interest in a share of<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BML PrG<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_Series2PreferredStockMember', window );">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 2</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,200th interest in a share of<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BML PrH<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_Series4PreferredStockMember', window );">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 4</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,200th interest in a share of<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BML PrJ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_Series5PreferredStockMember', window );">Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 5</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,200th interest in a share of<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BML PrL<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember', window );">Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIII (and the guarantee related thereto)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIII (and the guarantee related thereto)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC/PF<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember', window );">5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIV (and the guarantee related thereto)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIV (and the guarantee related thereto)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC/PG<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_IncomeCapitalObligationNotesMember', window );">Income Capital Obligation Notes initially due December 15, 2066 of Bank of America Corporation</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Income Capital Obligation Notes initially due December 15, 2066 of Bank of America Corporation<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MER PrK<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember', window );">Senior Medium-Term Notes, Series A, Step Up Callable Notes, due November 28, 2031 of BofA Finance LLC (and the guarantee of the Registrant with respect thereto)</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Senior Medium-Term Notes, Series A, Step Up Callable Notes, due<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC/31B<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesKKPreferredStockMember', window );">Depositary Shares, each representing 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series KK</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series KK<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesLLPreferredStockMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of 5.000% Non-Cumulative Preferred Stock, Series LL</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 5.000% Non-Cumulative Preferred Stock, Series LL<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesNNPreferredStockMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of 4.375% Non-Cumulative Preferred Stock, Series NN</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 4.375% Non-Cumulative Preferred Stock, Series NN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrO<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesPPPreferredStockMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of 4.125% Non-Cumulative Preferred Stock, Series PP</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 4.125% Non-Cumulative Preferred Stock, Series PP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrP<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_SeriesQQPreferredStockMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of 4.250% Non-Cumulative Preferred Stock, Series QQ</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 4.250% Non-Cumulative Preferred Stock, Series QQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrQ<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember', window );">Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">BAC PrS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_SeriesEPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesGGPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesGGPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesHHPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesHHPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesLPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesLPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_Series1PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_Series1PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_Series2PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_Series2PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_Series4PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_Series4PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_Series5PreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_Series5PreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_IncomeCapitalObligationNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_IncomeCapitalObligationNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesKKPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesKKPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesLLPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesLLPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesNNPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesNNPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesPPPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesPPPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_SeriesQQPreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_SeriesQQPreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( $V)F%I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( $V)F%I :KMW[P   "L"   1
M9&]C4')O<',O8V]R92YX;6S-DL%.PS ,AE\%Y=ZZS09(49<+B!-(2$P"<8L<
M;XMHVB@Q:O?VI&7KA. !.,;^\_FSY :#PC[2<^P#17:4KD;?=DEAV(@#<U
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M@2";_-;;I/;=X Q\U*M:I60K$3]+!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F
M6/,,H68XWX=%FAHSU8NL.8T*;T'50.4_V]0-:/8--!R1!5XQF;8VH^1."CS<
M_N\-L,+$CN'MB[\!4$L#!!0    ( $V)F%INLVGH4PH  '-7   8    >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&ULU9QK<^(X%H;_BHK=V9JI2H+O-KU)J@B=
M=+.=$"9D9O92^\$!);C:MAC9Y/+O5S($F8QS#@$IF^D/S=5O7NE<'AN$#A\8
M_UY,*2W)8Y;FQ5%K6I:S3^UV,9[2+"X.V(SFXI5;QK.X% _Y7;N8<1I/JH.R
MM.U85M#.XB1O'1]6SPWY\2&;EVF2TR$GQ3S+8OYT0E/V<-2R6\]/7"5WTU(^
MT3X^G,5W=$3+7V9#+AZU5RJ3)*-YD;"<<'I[U.K:GTYL.Y!'5&_Y-:$/1>T^
MD6.Y8>R[?-"?'+4L:8FF=%Q*C5C<W-,>35,I)8S\OE1MK?ZH/+!^_UG]K!J]
M&,U-7- >2W]+)N7TJ!6UR(3>QO.TO&(/7^ER1+[4&[.TJ/XG#\OW6BTRGA<E
MRY8'"P=9DB]NX\?E3&QR@+,\P*E\+_Y0Y?)S7,;'AYP]$"[?+=3DG6JHU='"
M7)++L(Q*+EY-Q''E<8_=4TZ&(@*'[5+HR6?;X^6Q)XMCG5>.[<[X 7&</>)8
MCK]^>%O86'EQ5EZ<2L]]1>\S&\]%Q$O2SQ?Y)L/VGW/Q+M(O:5;\M\GB0M)K
MEI1)_:F8Q6-ZU!)96U!^3UO'?_N+'5A_!PR[*\,NI*X,7S_-&N<//CS:_P:8
M\%8FO,U,#"E/V(2<YA,B4J'1#ZRTBB<64']ES0<%3_,R*9_(%;U+BI+'PN,@
MSAJ-P3HGW<$W<GE&NA>G5_U>E_0NKX:75]WK_N4 <!FL7 :;N.SG8\9GC%=I
MMT=&I9A#PCCIL7E>\B=Q.VFT#HM_/@4<ABN'X28.SY*4DL$\NZ&\R0BL8>\'
MON,"9J*5F6@3,]?Q(^E/1-XEM\EX4:JO6X,5_6#?ZEA!8'4 >YV5O<XF]KJ3
MB:CW8N_Y#JG:R&7>&$)8T;8L,F"\G))K_B2&*5X3W1:P:ENJ^5IO,MN3CT3.
M7;.'O+$?PW*]:<Q35KZL_75S-3+8;S*WJH@A9_=)/FXF!JPYZ$'6%"ALL*W_
MP=J0%66<DG\GLU?+%%%T(L>'6IZMF&##7;V*85><(KUN!18(+0\RHKA@P^W\
MG(W%G RG+(>Z!B+B1L&^'T0VY$CAP(;[^&\\$<F9BXG)LGF^;!M%HRM8Z#9.
M"S#)5>^WX?X\8FDR3LHDOR,7(KUY$J>-?F 5U(_J]#;<IH><[H_%]%!17XM3
M"YI/Q!G:Y>WM*_&#]5!GJNW;<)?^@[-^4<R%,]0@+(L:5(W?WJCSGV:4W\EX
M?A$*HFF+9)O%^5.C-5@0L^:H/N]LU.=[8MJXJ,F^F+%'\HTVFD*D+/DOM"(_
M@IRI)N_ #;DK0CFIPGF6QG>-?F !=))J9_]P"Y9=H<(K&W_?([.8D_LXG5/R
M5^O LLE,Y%@A^-;846'E+:\"'-7R'=? A0M(@6T]*SHX<&._3DIQ-LENB>W\
M>/,3&='Q7'3GYHR$E;:*V[IK11 ';OS7/)[(VAX]93>LL5,C B==Z S$4=QP
M$&XLYXN</HZG<7Y'7[VT080&_QI!EPB.(H<#=_K/=,:*I(S%I<I(SK<X+:+Q
M>$HXK?(GKQ@7$[MM[XD.(AICD@O>T:(4=\3S58QD/IRE+*[>>R5/]P8LW^_-
MLWD:RT]/Q*D?%6V>T\ESN$<"F;0@IXTC!PUOF^$*6$YDH"I!6FWK63',@9'S
MEJJ$E;2D@ZY\6/]T16'3A5F'5SLB(*I=6 3-*%*Z,.@VKWA$"*EX5P'3A8&I
MJ^*# _'R#YN&]LN7QC$;^1RN]D&< 0*[)@CL*@*[V@B,*'V,1%B?!H5T=U>D
M(P*+(C^!S"BLN[JPC@AA1:ZP[KX/UOV#*/3QV'[]VCA8$R1W%<E= R1W39#<
M521WM9$<47KG#%A6]\M$6/]N0B'<VQ7AB,"BNL$O2A3"/5T(1X20ZO84PCT8
MX>&!TQ 2RF>TG,<IZ;'\GO(RN4E?#]1YHW\3./84CCT#./9,X-BK?8VF#<>(
MDOZ@K@])H=7;%:V(P*+X0#,*K9XNM")"6/$IM'K:T.I C?4DSK_+VVXF@C>6
MG_NOOD?<[NK);IP5$PSV%(,] PSV3##84PSVM#$84=*4*M!WZ@JI_JY(101.
M+LY%ZD%G[[Y"JJ\+J8@04M6^0JJO[:KX?:O::9P5$Z#V%:A] Z#V38#:5Z#V
MM8$:47J'JJXME=F5U8C HJJALW9?L=K7Q6I$"*MJQ6K_3\IJKW%63+#:5ZSV
M#;#:-\%J7[':U\9J1,E\50>*U<&NK$8$%E7]#\B,8G6@B]6($%+5@6)U\"=E
MM=\X*R98'2A6!P98'9A@=:!8'6AC-:+T#E6M6!WLRFI$8%'5T'5U4%N]JHO5
MB!!6U8K5 <SJ]8I3)?;UZ88GDVJA;4;)->79<T+(DI-EW.V17CQ+Y%J^:SX7
ML?MGO]\G/\;YA)132N[FL5Q%3*F(NBA@6CW+:<E^:ARN"0@'"L*! 0@')B <
M* @'VB",*/W?<V!]H;4"=K@KL!$!X;\]/(.\*%Z'NGB-""&5'2I>AS"O_8/
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MW='K3.\?)H]:1NO<2KGW\$JV''..?[3\ 5!+ P04    " !-B9A:)!Z;HJT
M  #X 0  &@   'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O
M$N4 -5"I0P5,75@K+A %\R,2$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S
M)$9K!LIDR^SO *1;M(HNSN,P3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^
M0W1UW6E\./VR./ /,+Q=Z*E%9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@
MXLD@;6E6?;!/3K3G>1<W]T6NS>,)KM\,<'AT_@%02P,$%     @ 38F86F60
M>9(9 0  SP,  !,   !;0V]N=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;
M)2XL6*"F&V +77 !8T\:J_Z39UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=
M]=B4'5%\% )5!TYB'2)XKK0A.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T
M<F^I>.EY&TWP39G 8ED\C<+,:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JK
MA%SY'7#J>SM 2D9#L9&)7J5CE>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#
M(&?KT70Q32:>,(S/N]G\P68*R,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[
M04Y;@[Z1S>/]#&DWY(%B6.;/^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%0
M2P$"% ,4    " !-B9A:1L=-2)4   #-    $               @ $
M9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( $V)F%I :KMW[P   "L"   1
M              "  <,   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (
M $V)F%J97)PC$ 8  )PG   3              "  >$!  !X;"]T:&5M92]T
M:&5M93$N>&UL4$L! A0#%     @ 38F86FZS:>A3"@  <U<  !@
M     ("!(@@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    (
M $V)F%J?H!OPL0(  .(,   -              "  :L2  !X;"]S='EL97,N
M>&UL4$L! A0#%     @ 38F86I>*NQS     $P(   L              ( !
MAQ4  %]R96QS+RYR96QS4$L! A0#%     @ 38F86AE%%?4W 0  )P(   \
M             ( !<!8  'AL+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( $V)
MF%HD'INBK0   /@!   :              "  =07  !X;"]?<F5L<R]W;W)K
M8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    ( $V)F%IED'F2&0$  ,\#   3
M          "  ;D8  !;0V]N=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D
*/@(   ,:      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>20</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>19</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="bac-20250422.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.bankofamerica.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="bac-20250422.htm">bac-20250422.htm</File>
    <File>bac-20250422.xsd</File>
    <File>bac-20250422_def.xml</File>
    <File>bac-20250422_lab.xml</File>
    <File>bac-20250422_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="78">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "bac-20250422.htm": {
   "nsprefix": "bac",
   "nsuri": "http://www.bankofamerica.com/20250422",
   "dts": {
    "inline": {
     "local": [
      "bac-20250422.htm"
     ]
    },
    "schema": {
     "local": [
      "bac-20250422.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "bac-20250422_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "bac-20250422_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "bac-20250422_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 2,
   "memberCustom": 17,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 20,
   "entityCount": 1,
   "segmentCount": 19,
   "elementCount": 46,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 78
   },
   "report": {
    "R1": {
     "role": "http://www.bankofamerica.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "dei:DocumentType",
       "dei:DocumentType",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bac-20250422.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "dei:DocumentType",
       "dei:DocumentType",
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "bac-20250422.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "bac_A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIV (and the guarantee related thereto)",
        "label": "5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities [Member]",
        "documentation": "5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Domain]",
        "label": "Class of Stock [Domain]"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_CommonStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "CommonStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Common Stock, par value $0.01 per share",
        "label": "Common Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "bac_DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS",
        "label": "Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS [Member]",
        "documentation": "Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Line Items]",
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Information [Table]",
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "bac_FloatingRatePreferredHybridIncomeTermSecuritiesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "FloatingRatePreferredHybridIncomeTermSecuritiesMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIII (and the guarantee related thereto)",
        "label": "Floating Rate Preferred Hybrid Income Term Securities [Member]",
        "documentation": "Floating Rate Preferred Hybrid Income Term Securities [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_IncomeCapitalObligationNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "IncomeCapitalObligationNotesMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Income Capital Obligation Notes initially due December 15, 2066 of Bank of America Corporation",
        "label": "Income Capital Obligation Notes [Member]",
        "documentation": "Income Capital Obligation Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "bac_SeniorMediumTermNotesSeriesAStepUpCallableNotesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeniorMediumTermNotesSeriesAStepUpCallableNotesMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Senior Medium-Term Notes, Series A, Step Up Callable Notes, due November 28, 2031 of BofA Finance LLC (and the guarantee of the Registrant with respect thereto)",
        "label": "Senior Medium-Term Notes, Series A, Step Up Callable Notes [Member]",
        "documentation": "Senior Medium-Term Notes, Series A, Step Up Callable Notes [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_Series1PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "Series1PreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 1",
        "label": "Series 1 Preferred Stock [Member]",
        "documentation": "Series 1 Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_Series2PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "Series2PreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 2",
        "label": "Series 2 Preferred Stock [Member]",
        "documentation": "Series Two Preferred Stock member."
       }
      }
     },
     "auth_ref": []
    },
    "bac_Series4PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "Series4PreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 4",
        "label": "Series 4 Preferred Stock [Member]",
        "documentation": "Series Four Preferred Stock member."
       }
      }
     },
     "auth_ref": []
    },
    "bac_Series5PreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "Series5PreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depositary Shares, each representing a 1/1,200th interest in a share of Bank of America Corporation Floating Rate Non-Cumulative Preferred Stock, Series 5",
        "label": "Series 5 Preferred Stock [Member]",
        "documentation": "Series Five Preferred Stock member."
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_SeriesEPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "SeriesEPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of Floating Rate Non-Cumulative Preferred Stock, Series E",
        "label": "Series E Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesGGPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesGGPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of 6.000% Non-Cumulative Preferred Stock, Series GG",
        "label": "Series GG Preferred Stock [Member]",
        "documentation": "Series GG Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesHHPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesHHPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "verboseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of 5.875% Non-Cumulative Preferred Stock, HH",
        "label": "Series HH Preferred Stock [Member]",
        "documentation": "Series HH Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesKKPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesKKPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series KK",
        "label": "Series KK Preferred Stock [Member]",
        "documentation": "Series KK Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesLLPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesLLPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of 5.000% Non-Cumulative Preferred Stock, Series LL",
        "label": "Series LL Preferred Stock [Member]",
        "documentation": "Series LL Preferred Stock [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesLPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesLPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "netLabel": "7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L",
        "label": "Series L Preferred Stock [Member]",
        "documentation": "Series L Preferred Stock Member."
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesNNPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesNNPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of 4.375% Non-Cumulative Preferred Stock, Series NN",
        "label": "Series NN Preferred Stock [Member]",
        "documentation": "Series NN Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesPPPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesPPPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of 4.125% Non-Cumulative Preferred Stock, Series PP",
        "label": "Series PP Preferred Stock [Member]",
        "documentation": "Series PP Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "bac_SeriesQQPreferredStockMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.bankofamerica.com/20250422",
     "localname": "SeriesQQPreferredStockMember",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Depositary Shares, each representing a 1/1,000th interest in a share of 4.250% Non-Cumulative Preferred Stock, Series QQ",
        "label": "Series QQ Preferred Stock [Member]",
        "documentation": "Series QQ Preferred Stock"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Class of Stock [Axis]",
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.bankofamerica.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000070858-25-000195-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000070858-25-000195-xbrl.zip
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MR>$9=\J8>:]72WH-M000FFOH\^<=4)%1:Q5]^;(#*C)KK:)O.Z AJ]8:4G9
M0W:M-:3N@(:<6FM(WP$-*7*M563L@HK6/G5?DXH^!1%-_?#J'.Z:ZNG+I!?[
MWE'H1D-VR>+A!7/'L9^"+E^G\NH8<$#E=8R6J7WR;YB71D*1H,@Z1B=0D9F&
MNG3DIS0X[07^%8_;GT3I:]54?2,4H1_%Q\SSQT/T**ZB;)SK7*1L]'W4I4%
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M101]F)41&8WC9(P0 2!S/@9'TE4CAXL[*8 =-R5O%(MT/YT359-;<&.9J:C
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M]NFEL,]X)NP#Z#-;</D?93'O\V<!>BOXG/XXZ)D%Z'T0H+=F!:P,>I8 O;6
MGE$*].SG SVC95M&:=#[\D6 W@H^9SP.>DX!>@LV)!*@]ZP*6!7T-%F WEI
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MZ%CM-=4%#\^==IR5HM^6@F<=XX-O6Q5.B2Z;&E%1J^LYS+*D8@^7* G_;/@
M[4V=3'X(A 5 -A?,9RZ7;B:6DH>26V:Y0\D%P J +0"V_P!D2@"4"_'7[]^%
MW@&@*PN8BZO&PH@?X3U.&+\+NLY"#U>3P9W9B>MX7*H?>6C5O*Y@@I7S)#8$
M@1#Z!E=B]M-/X+D^3U5$IZ2N&XTS7I^D-/1H["5D%$<_?6_9^>':&SH]/WP6
MFUMK@IJJJ/IL:,/5.?7^)WE[]O#]4^-G'KMS2CV?B(&\VWSE($R?EIY;G^.
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M$LT6O(*S>MK "LF1FA6+]2>@_*3R@A8%1SN#<YRO^\URT6'%58LCD1EN<E>
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M?W<N[U33/?(PM-2'C]63T6K-1S;M9MWZV*I]CP==7-2>NU!<*)X(;=@$D8#
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M3@/Q#(  -58'&<&"&AJ6+SLQ+BM]1_5+2'I)O#8CN**&:J@5":,Y6#P_N>O
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M#\ET(&4MX]UR7G0'(-J\]B,F3EL'#]1C+5X45Y"::CUGK;4&G4KMP98BDJ9
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MX;XQ,B_[W3K9H1/C5.5N&)OA9-\*BEX4,WAU>7,<ECDNE2 (AM<8C.%BB9\
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MR[I*L@PD]EFA%NV+D^.SZ<S]+6VG_;6ST2D(JZKWM-/?)>7[J%I$UTOX?IK
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MH(A^O"]5/8;=A$/R>5[_J)5I;O/5&%8G?">!.976^9RM=W N;DF*\89[NR:
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MGIQ>,V4,5AEV@8"L33$0*DZN#MS#9XKDGN17?QQ,):YC(O?K3>DRW\''OMO
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M!UZ6X\D8+J<(O8#E>FD6R\'^]RC_T*W\0)]&6?/XX\]M?"JY2_*"!(K"Y_@
MMG#8]OHWPE2(703OS[0'Z0W2"$UGGK>79!BDI#%V6'2G%Q/C(,;6@%QHI\JX
M/W=5SOD?9)*OUO/6:Z\GJ_.4S_P]\IG/G_*9G]K<P$-F, %9I:20#73[9M@9
M<L(36%GDLI<YU&7J YQQRTF& 6=1%1(N$?R*M5<8Z<%1+'Q^+9G1^ZI^#T]/
M425D:VEFEZFDO8U=%CN"'/5(JF/MX''@172-X#;D?KW/FT^2"YV-"MFO UEG
M4WWWO_/C7J@V1^_YH0K_8:V++V4BU^:J0*G['F^Q/5OM[[:%%,EV,-LA..^;
MFYJ]^;([N\2;'=W1;IRV<^\1=)/<1;(X_BL!>P<,HQG2M<W.'9L=06!,?@UF
M#EW%V*-U4:WKZ!:>B28A9X]@@0K"")V='\>P</C_QGY<@4=INK7*[YBH6=5>
ME04ZL73*V < [YU+:$]Y9&>N744P560$8EX_#:=/\:(MR'@1-QM]3_5AE1/$
ML4A6#5-I.  T#1?K].M\8)5X5B\GD3(D?(2Q%^Z[,_K854S&U<!BS087Z]70
M8X^)4F_6?ZQ2I?/@V7GWP;$\^?70D\_IR:?@WE$U@'3M,8]\WGNB//"O6U<
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M&#=\/C0:!NM5&/U,U %LG$EC1CT>SU&G6HTM33CXNR[_*7Z#.J9UE7)M?^/
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M]=\"/_<KKRS\G(@*MF'//QWRNI.I<=2CX?)PPKIPW^J':2/!R:7BJ)WA=D%
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M#=Y)#&.Z11P;L/H1L?6Q98X6W&1F<9_(IJ-5:)/33;?O[8XHM8>Z6$HH-M3
MTF1,";N1V"&&%[U[.7?%P:0;G)N\B60KCO*)#U3KQFX\7PZV!8YD @]!A(I9
M3DX6Z*"&S<*[M5#!Y^"V&%N;V7IS=T"X+'F)@H3LP+EK:VB9<(;BB*YV'G%T
M8^$AO=S&0[K? ,KKH+4_Y-3^KN!4K9;76EFX0S":8D"A/0%9PT#6CPE<?%;@
MZ]Z93I\84G?-Z9P^Y73V@!.ZFGH1P[_#J<*>)2.YVJZF,V]X+XW[O__$@"G
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M;K3.QB^H%55 V&_"!5:"V5%(8T:\XY 4P /5='.=MKR',M-FJ7AB[UZ_A$^
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M"T)RA+Q<8P<])#I+((5Z*HJNX[1[L:M:I368@_REX=7HM_P9S_I$WG_ T,-
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MG]'\HO]9?L@!9,0NP06*P&>X W>4 89[YO]P$4U^<B1X;9*WFA<%G3MN&IR
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M(J>6 ;HU(16+38X&P5%_/S@ZZ'.)DN*$_ER.$[[5E2*"< 0*X)8$5Y'@PT0
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M%_$\-[J?RBV3( 4<"<$W<I6O1%M(CW(N#O4F!M*?!,C]#"(MV>*>:ZR$#^T
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M:R8%K#M6!N3:IB-AQFYYJE:A-2JQQTK@FJ69"<L3&UB]&F9ROBTXDBSID63
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M4$L! A0#%     @ 38F86OO'[RV6(0  A,8! !               ( !
M &)A8RTR,#(U,#0R,BYH=&U02P$"% ,4    " !-B9A:UW,A63X$  #_&
M$               @ '$(0  8F%C+3(P,C4P-#(R+GAS9%!+ 0(4 Q0    (
M $V)F%I-)#F(Q L  ,-=   4              "  3 F  !B86,M,C R-3 T
M,C)?9&5F+GAM;%!+ 0(4 Q0    ( $V)F%J'MMM2#Q4  -O(   4
M      "  28R  !B86,M,C R-3 T,C)?;&%B+GAM;%!+ 0(4 Q0    ( $Z)
MF%KK474_F0L  '1D   4              "  6='  !B86,M,C R-3 T,C)?
M<')E+GAM;%!+ 0(4 Q0    ( $Z)F%K/_$EE0U(  -$U @ 1
M  "  3)3  !E>#$P,2TT>#(R>#(U+FAT;5!+ 0(4 Q0    ( $Z)F%K@ .TA
ME34  -Y7 0 )              "  :2E  !E>#DY,2YH=&U02P4&      <
,!P"X 0  8-L

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>bac-20250422_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:bac="http://www.bankofamerica.com/20250422"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="bac-20250422.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:SeriesEPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesGGPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesHHPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesLPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series1PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series2PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series4PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:Series5PreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:FloatingRatePreferredHybridIncomeTermSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:A5.63FixedtoFloatingRatePreferredHybridIncomeTermSecuritiesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:IncomeCapitalObligationNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeniorMediumTermNotesSeriesAStepUpCallableNotesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesKKPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesLLPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesNNPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesPPPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:SeriesQQPreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000070858</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">bac:DepositarySharesEachRepresentingA11000thInterestInAShareOf4750NonCumulativePreferredStockSeriesSSMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-04-22</startDate>
            <endDate>2025-04-22</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-77">0000070858</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-78">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentType contextRef="c-1" id="f-2">8-K</dei:DocumentType>
    <dei:DocumentType contextRef="c-1" id="f-3">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-4">2025-04-22</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-5">BANK OF AMERICA CORPORATION</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-6">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-7">1-6523</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-8">56-0906609</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-9">100 North Tryon Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-10">Charlotte</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-11">NC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-12">28255</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-13">704</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-14">386-5681</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-15">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-16">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-18">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-2" id="f-19">Common Stock, par value $0.01 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-2" id="f-20">BAC</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-2" id="f-21">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-3" id="f-22">Depositary Shares, each representing a 1/1,000th interest in a share  of Floating Rate Non-Cumulative Preferred Stock, Series E</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-3" id="f-23">BAC PrE</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-3" id="f-24">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-4" id="f-25">Depositary Shares, each representing a 1/1,000th interest in a share of 6.000% Non-Cumulative Preferred Stock, Series GG</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-4" id="f-26">BAC PrB</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-4" id="f-27">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-5" id="f-28">Depositary Shares, each representing a 1/1,000th interest in a share of 5.875% Non-Cumulative Preferred Stock, Series HH</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-5" id="f-29">BAC PrK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-5" id="f-30">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-6" id="f-31">7.25% Non-Cumulative Perpetual Convertible Preferred Stock, Series L</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-6" id="f-32">BAC PrL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-6" id="f-33">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-7" id="f-34">Depositary Shares, each representing a 1/1,200th interest in a share of</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-7" id="f-35">BML PrG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-7" id="f-36">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-8" id="f-37">Depositary Shares, each representing a 1/1,200th interest in a share of</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-8" id="f-38">BML PrH</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-8" id="f-39">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-9" id="f-40">Depositary Shares, each representing a 1/1,200th interest in a share of</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-9" id="f-41">BML PrJ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-9" id="f-42">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-10" id="f-43">Depositary Shares, each representing a 1/1,200th interest in a share of</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-10" id="f-44">BML PrL</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-10" id="f-45">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-11" id="f-46">Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIII (and the guarantee related thereto)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-11" id="f-47">BAC/PF</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-11" id="f-48">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-12" id="f-49">5.63% Fixed to Floating Rate Preferred Hybrid Income Term Securities of BAC Capital Trust XIV (and the guarantee related thereto)</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-12" id="f-50">BAC/PG</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-12" id="f-51">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-13" id="f-52">Income Capital Obligation Notes initially due December 15, 2066 of Bank of America Corporation</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-13" id="f-53">MER PrK</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-13" id="f-54">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-14" id="f-55">Senior Medium-Term Notes, Series A, Step Up Callable Notes, due</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-14" id="f-56">BAC/31B</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-14" id="f-57">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-15" id="f-58">Depositary Shares, each representing a 1/1,000th interest in a share of 5.375% Non-Cumulative Preferred Stock, Series KK</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-15" id="f-59">BAC PrM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-15" id="f-60">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-16" id="f-61">Depositary Shares, each representing a 1/1,000th interest in a share of 5.000% Non-Cumulative Preferred Stock, Series LL</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-16" id="f-62">BAC PrN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-16" id="f-63">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-17" id="f-64">Depositary Shares, each representing a 1/1,000th interest in a share of 4.375% Non-Cumulative Preferred Stock, Series NN</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-17" id="f-65">BAC PrO</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-17" id="f-66">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-18" id="f-67">Depositary Shares, each representing a 1/1,000th interest in a share of 4.125% Non-Cumulative Preferred Stock, Series PP</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-18" id="f-68">BAC PrP</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-18" id="f-69">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-19" id="f-70">Depositary Shares, each representing a 1/1,000th interest in a share of 4.250% Non-Cumulative Preferred Stock, Series QQ</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-19" id="f-71">BAC PrQ</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-19" id="f-72">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle contextRef="c-20" id="f-73">Depositary Shares, each representing a 1/1,000th interest in a share of 4.750% Non-Cumulative Preferred Stock, Series SS</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-20" id="f-74">BAC PrS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-20" id="f-75">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-76">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
